Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 62
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An Experimental and methodological approach of plant fibres in dental calculus, the case study of the Early Neolithic Site of Cova del Pasteral (Girona, Spain)

  • Herrero Otal, Maria|||0000-0002-3846-1238
  • Canales Bartra, Laura
  • Agustí, Bibiana
  • Rosillo Turra, Rafael|||0000-0003-3007-6981
  • Bosch Lloret, Àngel|||0000-0003-0275-1337
  • Barberà Berrocal, Anna|||0000-0003-4379-5635
  • Palomo Pérez, Antoni|||0000-0001-9954-7310
  • Piqué Huerta, Raquel|||0000-0002-8253-6874
  • Terradas, Xavier|||0000-0002-8000-5607
  • Malgosa Morera, Assumpció|||0000-0003-1723-3671
Perishable organic raw materials such as plant fibres have been widely used since the time of the earliest human groups, although their poor preservation limits our knowledge of their use. Filling this gap requires a focused search for plant fibre evidence in non-perishable materials. Since teeth are sometimes used in fibre processing, evidence of fibres can be sought in mineralised bacterial plaque, and therefore, its analysis can potentially be useful in the study of plant-human relationships. Experimental protocols have been tested to improve the recovery of microremains in dental calculus, although these are typically focused on microremains other than plant fibres. This article investigates the possibility that plant fibres are identified less often in dental calculus because the corrosive agents used cause their disappearance. Ethylenediaminetetraacetic acid (EDTA) and hydrochloric acid agents at 0.2 and 0.5 M were applied for 5, 30, 90, and 170 h to six different modern plant fibres considering their use in archaeological craft activities and showed that none of the procedures affected their characteristics. After testing the same approach on medieval control dental calculus samples, a selected methodology (0.5 M EDTA) was applied to ancient dental calculus from the Neolithic site of Cova del Pasteral (La Cellera de Ter, NE Spain) as a case study to identify the plant fibres present in it.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Isotope and morphometrical evidence reveals the technological package associated with agriculture adoption in western Europe

  • Araus, José L.|||0000-0002-8866-2388
  • Gascon, Mireia|||0000-0003-4537-8472
  • Ros-Sabé, Eva|||0000-0002-6635-9230
  • Piqué Huerta, Raquel|||0000-0002-8253-6874
  • Rezzouk, Fatima Zahra|||0000-0002-1850-718X
  • Aguilera Pujabet, Mònica|||0000-0003-0763-7947
  • Voltas, Jordi|||0000-0003-4051-1158
  • Peña-Chocarro, Leonor|||0000-0002-7807-8778
  • Pérez Jordà, Guillem|||0000-0003-1459-0219
  • Terradas, Xavier|||0000-0002-8000-5607
  • Palomo Pérez, Antoni|||0000-0001-9954-7310
  • Ferrio, Juan Pedro|||0000-0001-5904-7821
  • Antolín, Ferran|||0000-0002-0533-5788
The emergence and spread of agriculture represented a landmark in societal development, triggering the Neolithic revolution. The spread of agriculture from the Fertile Crescent to the western edge of Europe has been extensively researched, but our knowledge of the actual crop husbandry practices is still limited. We followed a dual approach: in-depth study of La Draga, one of the earliest agricultural settlements in the western Mediterranean and exceptional for its abundance and preservation of archaeobotanical remains, together with a regional perspective including other early agricultural sites. Our results support archaeological models of agriculture diffusion and denote favorable water conditions and evolved crop characteristics when agriculture reached Europe's western edge. This study aimed to reconstruct the environmental conditions and the crop management practices and plant characteristics when agriculture appeared in western Europe. We analyzed oak charcoal and a large number of cereal caryopsides recovered from La Draga (Girona, Spain), an early (5300 to 4800 cal. BC) agricultural site from the Iberian Peninsula. The carbon isotope discrimination (Δ 13 C) values of oak, the dominant forest species in the region, indicates prevalence of a wet climate at the site. Further, we reconstructed crop management conditions, achievable yield, and crop characteristics through the analysis of Δ 13 C, nitrogen isotope composition (δ 15 N), nitrogen content, and the reconstructed weight of wheat and barley caryopsides, following protocols developed by our team [Araus et al., Nat. Commun. 5, 3953 (2014)] and comparison of these parameters with present-day organic agriculture in the region. In parallel, a regional perspective was achieved through the study of wheat and barley grains of seventeen Neolithic sites from the western Mediterranean. The results suggest that rather than small-garden cultivation, a more extensive agriculture was practiced under good water availability and moderate manuring. Moreover, results from La Draga evidence that grain weight and spike morphology were comparable to contemporary cereals. Growing conditions and the prevalence of improved crop traits indicate that agriculture was fairly consolidated at the time it reached the western edge of Europe.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Association Between the Mediterranean Diet and Fatty Acids in Red Blood Cells of Spanish Adolescents

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Lafuente, David
  • Lázaro, Iolanda|||0000-0002-6172-9845
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • Manidis, Alexios
  • Bernardo-Castro, Sara|||0000-0001-8809-5101
  • Fernández-Barrés, Sílvia|||0000-0002-9977-2291
  • Healy, Darren|||0000-0002-0084-2289
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Sala-Vila, Aleix|||0000-0002-5038-2794
  • Júlvez, Jordi|||0000-0003-0818-4003
Objective: The Mediterranean diet (MedDiet) is characterized by its emphasis on plant-based foods, olive oil, and fish products, and has been associated with providing relevant fatty acids (FAs) for adolescent physiology. This study aims to investigate the relationship between adherence to the MedDiet and the FA composition of red blood cell (RBC) membranes in an adolescent population. Methods: The current research examines the relationship between MedDiet adherence, assessed using the KIDMED questionnaire, and the composition of RBC membranes, specifically measuring 22 FAs in a cross-sectional analysis of adolescents from two cohorts (mean age = 14.55). Baseline data from 552 participants with complete dietary adherence and FA information were analyzed using multivariable regression models and principal component analysis (PCA) as confirmatory analysis. All regression models were adjusted by age, sex, body mass index, physical activity, maternal education and cohort enrollment. Results: Main results shown that "Good adherence" to the MedDiet was positively associated with omega-3 FAs, including eicosapentaenoic acid (β = 0.34; 95% CI: 0.17, 0.52; p -value < 0.001) and docosahexaenoic acid (β = 0.29; 95% CI: 0.11, 0.46; p -value = 0.001), and inversely associated with specific omega-6 FAs, such as arachidonic acid (β = -0.28; 95% CI: -0.46, -0.11; p -value = 0.002) and adrenic acid (β = -0.19; 95% CI: -0.30, -0.08; p -value < 0.001). PCA identified distinct FA patterns, with "Good adherence" to the MedDiet being associated with an increase in the omega-3 FAs pattern (β = 0.32; 95% CI: 0.14, 0.49; p -value < 0.001). These findings remained robust after multiple test comparisons. Conclusions: This study underscores the potential of the MedDiet to promote optimal RBC FA composition in healthy adolescents, characterized by high levels of omega-3 FAs and reduced levels of arachidonic acid and adrenic acid in RBC membranes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The link between ultra-processed food consumption, fecal microbiota, and metabolomic profiles in older mediterranean adults at high cardiovascular risk

  • Atzeni, Alessandro
  • Hernández-Cacho, Adrián
  • Khoury, Nadine
  • Babio, Nancy|||0000-0003-3527-5277
  • Belzer, Clara
  • Vioque, Jesús|||0000-0002-2284-148X
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Clish, Clary|||0000-0001-8259-9245
  • Vidal, Josep|||0000-0002-4564-4518
  • Konstanti, Prokopis
  • Gonzales-Palacios, Sandra
  • Coltell, Oscar
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Moreno Indias, Isabel
  • Carlos Chillerón, Silvia
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Hu, Frank B.
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Ultra-processed food (UPF) consumption has been linked to adverse metabolic outcomes, potentially mediated by alterations in gut microbiota and metabolite production. This study aims to explore the cross-sectional and longitudinal associations between NOVA-classified UPF consumption, fecal microbiota, and fecal metabolome in a population of Mediterranean older adults at high cardiovascular risk. A total of 385 individuals, aged between 55 and 75 years, were included in the study. Dietary and lifestyle information, anthropometric measurements, and stool samples were collected at baseline and after 1-year follow-up. Fecal microbiota and metabolome were assessed using 16 S rRNA sequencing and liquid chromatography-tandem mass spectrometry, respectively. At baseline, higher UPF consumption was associated with lower abundance of Ruminococcaceae incertae sedis (β = - 0.275, P = 0.047) and lower concentrations of the metabolites propionylcarnitine (β = - 0.0003, P = 0.013) and pipecolic acid (β = - 0.0003, P = 0.040) in feces. Longitudinally, increased UPF consumption was linked to reduced abundance of Parabacteroides spp. after a 1-year follow-up (β = - 0.278, P = 0.002). High UPF consumption was associated with less favorable gut microbiota and metabolite profiles, suggesting a possible link to reduced short-chain fatty acid (SCFA) production, altered mitochondrial energy metabolism, and impaired amino acid metabolism. These findings support the reduction of UPF consumption and the promotion of dietary patterns rich in fiber for better gut health. Further research is needed to confirm these associations and clarify the underlying mechanisms. : ISRCTN89898870 (10.1186/ISRCTN89898870). The online version contains supplementary material available at 10.1186/s12937-025-01125-5.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive analysis of the relationship between ultra-processed food consumption and food addiction at one-year follow-up in older adults with metabolic syndrome

  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Vázquez-Lorente, Héctor|||0000-0003-0183-6902
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Gomis-González, Maria|||0000-0001-9778-4849
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
BACKGROUND: Ultra-processed foods (UPFs) are theorised to exhibit addictive properties within the framework of the Food Addiction (FA) model, attributable to their high palatability, sugars, salt, saturated/trans fats, and caloric density. AIMS: To evaluate the association between UPFs consumption and FA presence, and to examine whether reducing UPFs intake after one year of intervention is associated to decreased FA scores. METHODS: The sample included 429 Mediterranean older adults with overweight/obesity and metabolic syndrome from the PREDIMED-Plus-Cognition sub-study. FA presence was evaluated with the Yale Food Addiction Scale 2.0, and the nutritional information through validated food frequency questionnaires. UPFs was categorised according to the NOVA system and divided into consumption tertiles. Data were analysed using repeated measures ANOVA, structural equation modelling, and logistic regression to compare FA changes across tertiles of UPF reduction after one-year follow-up. RESULTS: Baseline YFAS categorisation into three levels (positive-probable-negative) showed significant differences between the second and third tertile of UPFs consumption, with the highest tertile of consumption having greater likelihood of worse FA status. After one year, the likelihood of change in the FA levels was higher only for individuals within the highest decreases in the UPFs consumption (OR = 1.67, p = 0.040). DISCUSSION AND CONCLUSIONS: These findings indicate that a reduction in the consumption of UPFs may contribute to the improvement of FA symptoms, providing novel insights into the association between UPFs and the presence of FA. Future research should focus on populations with higher UPFs consumption and investigating the long-term effects of dietary quality on FA symptoms.
Repisalud
Publication Artículo científico (JournalArticle)

Kpi, a chaperone-usher pili system associated with the worldwide-disseminated high-risk clone Klebsiella pneumoniae ST-15

  • Gato, Eva
  • Vázquez-Ucha, Juan Carlos
  • Rumbo-Feal, Soraya
  • Álvarez-Fraga, Laura
  • Vallejo, Juan A
  • Martínez-Guitián, Marta
  • Beceiro, Alejandro
  • Ramos Vivas, Jose
  • Sola-Campoy, Pedro Juan
  • Perez-Vazquez, Maria
  • Rodiño-Janeiro, Bruno Kotska
  • Romero, Antonio
  • Poza, Margarita
  • Bou, Germán
  • Oteo-Iglesias, Jesus
  • Perez Gomez, Astrid
Control of infections caused by carbapenem-resistant Klebsiella pneumoniae continues to be challenging. The success of this pathogen is favored by its ability to acquire antimicrobial resistance and to spread and persist in both the environment and in humans. The emergence of clinically important clones, such as sequence types 11, 15, 101, and 258, has been reported worldwide. However, the mechanisms promoting the dissemination of such high-risk clones are unknown. Unraveling the factors that play a role in the pathobiology and epidemicity of K. pneumoniae is therefore important for managing infections. To address this issue, we studied a carbapenem-resistant ST-15 K. pneumoniae isolate (Kp3380) that displayed a remarkable adherent phenotype with abundant pilus-like structures. Genome sequencing enabled us to identify a chaperone-usher pili system (Kpi) in Kp3380. Analysis of a large K. pneumoniae population from 32 European countries showed that the Kpi system is associated with the ST-15 clone. Phylogenetic analysis of the operon revealed that Kpi belongs to the little-characterized γ2-fimbrial clade. We demonstrate that Kpi contributes positively to the ability of K. pneumoniae to form biofilms and adhere to different host tissues. Moreover, the in vivo intestinal colonizing capacity of the Kpi-defective mutant was significantly reduced, as was its ability to infect Galleria mellonella The findings provide information about the pathobiology and epidemicity of Kpi+K. pneumoniae and indicate that the presence of Kpi may explain the success of the ST-15 clone. Disrupting bacterial adherence to the intestinal surface could potentially target gastrointestinal colonization.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Probability fields revisited in the context of ensemble Kalman filtering

  • Xu, Teng
  • Gómez-Hernández, J. Jaime|||0000-0002-0720-2196
Hu et al. (2013) proposed an approach to update complex geological fades models generated by multiple-point geostatistical simulation while keeping geological and statistical consistency. Their approach is based on mapping the fades realization onto the spatially uncorrelated uniform random numbers used by the sequential multiple-point simulation to generate the facies realization itself. The ensemble Kalman filter was then used to update the uniform random number realizations, which were then used to generate a new fades realization by multiple-point simulation. This approach has not a good performance that we attribute to the fact that, being the probabilities random and spatially uncorrelated, their correlation with the state variable (piezometric heads) is very weak, and the Kalman gain is always small. The approach is reminiscent of the probability field simulation, which also maps the conductivity realizations onto a field of uniform random numbers; although the mapping now is done using the local conditional distribution functions built based on a prior statistical model and the conditioning data. Contrary to Hu et al. (2013) approach, this field of uniform random numbers, termed a probability field, displays spatial patterns related to the conductivity spatial patterns, and, therefore, the correlation between probabilities and state variable is as strong as the correlation between conductivities and state variable could be. Similarly to Hu et al. (2013), we propose to use the ensemble Kalman filter to update the probability fields, and show that the existence of this correlation between probability values and state variables provides better results., The first author acknowledges the financial support from the China Scholarship Council (CSC). Part of this work was done while the second author was on sabbatical with the Kansas Geological Survey, Kansas University, Lawrence, KS, USA, which was funded by the Spanish Ministry of Education, Culture and Sports through grant PRX14/00501. Financial support to carry out this work was also received from the Spanish Ministry of Economy and Competitiveness through project CGL2014-59841-P.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Linear elastic mechanical system interacting with coupled thermo-electro-magnetic fields

  • Moreno-Navarro, Pablo|||0000-0002-2787-976X
  • Ibrahimbegovich, A.
  • Pérez-Aparicio, José L.
[EN] A fully-coupled thermodynamic-based transient finite element formulation is proposed in this article for electric, magnetic, thermal and mechanic fields interactions limited to the linear case. The governing equations are obtained from conservation principles for both electric and magnetic flux, momentum and energy. A full-interaction among different fields is defined through Helmholtz free-energy potential, which provides that the constitutive equations for corresponding dual variables can be derived consistently. Although the behavior of the material is linear, the coupled interactions with the other fields are not considered limited to the linear case. The implementation is carried out in a research version of the research computer code FEAP by using 8-node isoparametric 3D solid elements. A range of numerical examples are run with the proposed element, from the relatively simple cases of piezoelectric, piezomagnetic, thermoelastic to more complicated combined coupled cases such as piezo-pyro-electric, or piezo-electro-magnetic. In this paper, some of those interactions are illustrated and discussed for a simple geometry., This work was supported jointly by Hauts-de-France Region (CR Picardie) (120-2015-RDISTRUCT-000010 and RDISTRUCT-000010) and EU funding (FEDER) for Chaire-de-Mecanique (120-2015-RDISTRUCTF-000010 and RDISTRUCTI-000004). Also, by the grant Ministerio de Educacion, Cultura y Deporte PRX16/00501. This support is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Topical Administration of a Marine Oil Rich in Pro-Resolving Lipid Mediators Accelerates Wound Healing in Diabetic db/db Mice through Angiogenesis and Macrophage Polarization

  • Amaro-Prellezo, Elena
  • Ontoria-Oviedo, Imelda
  • Castellano, Delia
  • Venegas-Venegas, Elena
  • González-Santos, Fernando
  • Ruiz-Saurí, Amparo
  • Pelacho, Beatriz
  • Prósper, Felipe
  • Pérez del Caz, María Dolores
  • Sepúlveda, Pilar
[EN] Impaired wound healing in patients with type 2 diabetes (DM2) is characterized by chronic inflammation, which delays wound closure. Specialized pro-resolving lipid mediators (SPMs) are bioactive molecules produced from essential polyunsaturated fatty acids (PUFAs), principally omega-3 docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). SPMs are potent regulators of inflammation and have been used to suppress chronic inflammation in peripheral artery disease, non-alcoholic fatty liver disease, and central nervous system syndromes. LIPINOVA® is a commercially available safe-grade nutritional supplement made from a fractionated marine lipid concentrate derived from anchovy and sardine oil that is rich in SPMs and EPA, as well as DHA precursors. Here, we assessed the effect of LIPINOVA® in wound dressing applications. LIPINOVA® showed biocompatibility with keratinocytes and fibroblasts, reduced the abundance of pro-inflammatory macrophages (M¿1), and promoted in vitro wound closure. Daily application of the marine oil to open wounds made by punch biopsy in db/db mice promoted wound closure by accelerating the resolution of inflammation, inducing neoangiogenesis and M¿1/M¿2 macrophage polarization. In conclusion, LIPINOVA® displays pro-resolutive properties and could be exploited as a therapeutic agent for the treatment of diabetic ulcers., This work was supported by the RETICS Program (RD16/0011/0004 and RD16/0011/0005) of the Instituto de Salud Carlos III, co-funded by FEDER 'una manera de hacer Europa,' and by PROJECT RESOLTEX (RTC-2015-4185-1) of the Ministerio de Economia y Competitividad through the RETOS program. It was also supported by grant ACIF/2020/352 to E.A.-P. from the Conselleria de Innovacion, Universidades, Ciencia, y Sociedad Digital and co-financed by the European Union through the Operational Program of the European Regional Development Fund (FEDER) of the Valencian Community 2014-2020, and from the Instituto de Salud Carlos III, co-funded by FEDER, to P.S (PI19/00245) and B.P. (PI19/00501).
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Physical activity and metabolic syndrome severity among older adults at cardiovascular risk: 1-Year trends

  • Gallardo-Alfaro, Laura
  • Bibiloni, María del Mar
  • Bouzas Cristina
  • Mascaró, Catalina M.
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Schröder, Helmut
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López-Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Luis
  • Bueno-Cavanillas, Aurora
  • Micó, Rafael M.
  • Pintó, Xavier
  • Gaforio, José J.
  • Ortíz-Ramos, María
  • Altés-Boronat, Andreu
  • Luca, Bogdana L.
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayon-Orea, Carmen
  • Becerra-Tomás, Nerea
  • Gimenez-Alba, Ignacio Manuel
  • Castañer, Olga
  • Abete, Itziar
  • Tojal-Sierra, Lucas
  • Pérez-López, Jéssica
  • Torres-Collado, Laura
  • Colom, Antoni
  • Garcia-Rios, Antonio
  • Castro-Barquero, Sara
  • Bernal, Rosa
  • Santos-Lozano, José Manuel
  • Fernandez-Lazaro, César I.
  • Hernández-Alonso, Pablo
  • Saiz, Carmen
  • Zomeño, María Dolores
  • Zulet, Maria Angeles
  • Belló-Mora, Maria C.
  • Basterra-Gortari, F. Javier
  • Canudas, Silvia
  • Goday, Albert
  • Tur, Josep A.
[eng] Background and aims: Modifiable lifestyle factors, such as physical activity (PA) and Mediterranean diet (MD), decrease metabolic syndrome (MetS). The aim was to assess 1-year changes of leisure-time physical activity (LTPA), sedentary behavior, and diet quality according to MetS severity in older population at high cardiovascular risk. Methods and results: Prospective analysis of 55–75-year-old 4359 overweight/obese participants with MetS (PREDIMED-Plus trial) categorized in tertiles according to 1-year changes of a validated MetS severity score (MetSSS). Anthropometrics, visceral adiposity index, triglycerides and glucose index, dietary nutrient intake, biochemical marker levels, dietary inflammatory index, and depression symptoms were measured. Diet quality was assessed by 17-item MD questionnaire. PAs were self-reported using the Minnesota-REGICOR Short Physical Activity Questionnaire and 30-s chair stand test. Sedentary behaviors were measured using the Spanish version of the Nurses’ Health Study questionnaire. After 1-year follow-up, decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high intake of vegetables, fruits, legumes, nuts, whole grain cereals, white fish, and bluefish and low intake of refined cereals, red and processed meat, cookies/sweets, and snacks/ready-to-eat-meals. It resulted in high intake of polyunsaturated fatty acids, omega-3 fatty acids, protein, fiber, vitamins B1, B6, B9, C, D, potassium, magnesium, and phosphorus and low glycemic index and saturated fatty acid, trans fatty acid, and carbohydrates intake. Regarding PA and sedentary behavior, decreasing MetSSS was associated with increased moderate-to-vigorous LTPA, chair stand test, and decreased sedentary and TV-viewing time. Conclusion: Decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high LTPA, high MD adherence, low sedentary time, and low depression risk.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, S.
  • Pastor, R.
  • Monserrat-Mesquida, M.
  • Álvarez-Álvarez, L.
  • Rubín-García, M.
  • Martínez-González, M.Á.
  • Salas-Salvadó, J.
  • Corella, D.
  • Goday, A.
  • Martínez, J.A.
  • Alonso-Gómez, Ángel M.
  • Wärnberg, J.
  • Vioque, J.
  • Romaguera, D.
  • Lopez-Miranda, J.
  • Estruch, R.
  • Tinahones, F.J.
  • Lapetra, J.
  • Serra-Majem, L.
  • Riquelme-Gallego, B.
  • Pintó, X.
  • Gaforio, J.J.
  • Matía, P.
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, L.
  • Ros, E.
  • Sayón-Orea, C.
  • Guillem-Saiz, P.
  • Valle-Hita, C.
  • Cabanes, R.
  • Abete, Itziar
  • Goicolea-Güemez, L.
  • Gómez-Gracia, E.
  • Tercero-Maciá, C.
  • Colom, A.
  • García-Ríos, A.
  • Castro-Barquero, S.
  • Fernández-García, J.C.
  • Santos-Lozano, J.M.
  • Cenoz, J.C.
  • Barragán, R.
  • Khoury, N.
  • Castañer, O.
  • Zulet, M.Á.
  • Vaquero-Luna, J.
  • Bes-Rastrollo, M.
  • de las Heras-Delgado, S.
  • Ciurana, R.
  • Martín-Sánchez, V.
  • Tur, J.A.
  • Bouzas, C.
[eng] Background: Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims: To assess the association between MetS severity and amount of carbon dioxide (CO2) emitted in an adult population. Design: Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods: Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results: Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions: Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga
  • Fiol, Miguel
  • Colom, Antoni
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Soria-Florido, María Trinidad
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • López-Miranda, José
  • Estruch, Ramon
  • Bernal-López, M. Rosa
  • Lapetra, José
  • Serra-Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Bes-Rastrollo, Maira
  • Pascual, María
  • Sorlí, Jose V.
  • Goday, Albert
  • Zulet, María Ángeles
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • Garcia-Rios, Antonio
  • Casas, Rosa
  • Gómez-Pérez, Ana M.
  • Santos-Lozano, José Manuel
  • Basterra-Gortari, F. Javier
  • Martínez, María Ángeles
  • Ortega-Azorin, Carolina
  • Bayó, Joan
  • Abete, Itziar
  • Salaverria-Lete, Itziar
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • Carres, Lourdes
  • Romaguera, Dora
[eng] Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p-values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS,
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Contribuciones a la comprensión lectora: mecanismos de atención y alineamiento entre n-gramas para similitud e inferencia interpretable, Contributions to language understanding: n-gram attention and alignments for interpretable similarity and inference

  • Lopez-Gazpio, Iñigo
Tesis doctoral titulada “Hizkuntza-ulermenari Ekarpenak: N-gramen arteko Atentzio eta Lerrokatzeak Antzekotasun eta Inferentzia Interpretagarrirako / Contribuciones a la Comprensión Lectora: Mecanismos de Atención y Alineamiento entre N-gramas para Similitud e Inferencia Interpretable”, defendida por Iñigo Lopez-Gazpio en la Universidad del País Vasco (UPV/EHU) y elaborada bajo la dirección de los doctores Eneko Agirre (Departamento de Lenguajes y Sistemas Informáticos) y Montse Maritxalar (Departamento de Lenguajes y Sistemas Informáticos). La defensa tuvo lugar el 30 de octubre de 2018 ante el tribunal formado por los doctores Kepa Sarasola (Presidente, Universidad del País Vasco (UPV/EHU)), Gorka Azkune (Secretario, Universidad de Deusto) y David Martínez (Vocal, IBM). La tesis obtuvo la calificación de sobresaliente Cum Laude y mención internacional.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Engineering low-endotoxin lipid A in a double auxotroph Pseudomonas aeruginosa to develop safer whole-cell vaccines

  • Fuentes-Valverde, Víctor
  • García, Patricia
  • Candela, Ana
  • Santamarina-Fernández, Rebeca
  • Avendaño-Ortiz, José
  • Martínez-Alonso, Emma
  • Oviaño, Marina
  • Cantón, Rafael
  • Arenas, Jesús
  • Moscoso, Miriam
  • Bou, Germán
[Abstract] Introduction: Pseudomonas aeruginosa is a highly adaptable Gram-negative bacterium causing severe respiratory infections, particularly in vulnerable populations. The rise of antimicrobial resistance highlights the urgent need for effective vaccines. We previously developed a live-attenuated vaccine candidate, PAO1 ΔmurI Δalr ΔdadX, a genetically stable double auxotrophic strain that exhibited dose-dependent reactogenicity upon intranasal administration in mice, likely due to lipid A component of lipopolysaccharide (LPS). Methods: To reduce LPS-associated toxicity while preserving immunogenicity, we engineered novel strains by inactivating genes involved in lipid A biosynthesis (htrB1, htrB2) or modification (pagP, pagL). Lipid A structural modifications were confirmed by MALDI-TOF MS. Mutants were evaluated for Toll-like receptor 4 (TLR4) activation, virulence attenuation, and their ability to induce immune responses and protection in an acute pneumonia model. Results: All engineered strains displayed modified lipid A structures. Mutations in htrB1 and htrB2 reduced TLR4 activation and significantly attenuated virulence following intraperitoneal challenge in mice. Inactivation of pagL resulted in minimal attenuation, whereas pagP inactivation led to marked attenuation without altering TLR4 activation. In the acute pneumonia model, all mutants elicited robust systemic and mucosal immune responses, and conferred strong protection, despite transient weight loss following intranasal administration. Discussion: Targeted lipid A modification represents an effective strategy to reduce in vitro reactogenicity while preserving immunogenicity in live-attenuated P. aeruginosa vaccine candidates. Although further optimization may minimize residual in vivo effects, these findings support the potential of engineered strains as vaccine candidates for preventing respiratory infections caused by P. aeruginosa., The author(s) declared that financial support was received for this work and/or its publication. This work was supported by a grant from the SERGAS-Galician Healthcare Service (Program “Innova Saúde”), CIBERINFEC, and the projects PI18/00501 and PI21/00704 to GB, and the project PI20/00686 to MO, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 from the Ministry of Economy and Competitiveness and the Institute of Health Carlos III. In addition, this work was supported by the Ciencia e Innovación/Agencia Española de Investigación MCIN/AEI/10.13039/501100011033 and, as appropriate, by ERDF A way of making Europe by the European Union or by the European Union Next Generation EU/PRTR (Grant agreement PID2020-114617RB-100) to JA. VF-V was funded with a predoctoral fellowship from the Conselleria de Cultura, Xunta de Galicia (IN606A-2019/012) and by the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) for a research stay (May-July 2022) at the University of Zaragoza. AC was financially supported by the Río Hortega program (ISCIII-SERGAS, CM21/00165).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Global transcriptomic analysis during murine pneumonia infection reveals new virulence factors in Acinetobacter baumannii

  • Martínez Guitián, Marta
  • Vázquez-Ucha, Juan Carlos
  • Álvarez-Fraga, Laura
  • Conde-Pérez, Kelly
  • Vallejo, J. A.
  • Perina Cedrón, Alejandra
  • Bou, Germán
  • Poza, Margarita
  • Beceiro Casas, Alejandro
[Abstract] Background: Infections caused by multidrug-resistant pathogens such as Acinetobacter baumannii constitute a major health problem worldwide. In this study we present a global in vivo transcriptomic analysis of A. baumannii isolated from the lungs of mice with pneumonia infection. Methods: Mice were infected with A. baumannii ATCC 17978 and AbH12O-A2 strains and the total bacterial RNA were analyzed by RNA sequencing. Lists of differentially expressed genes were obtained and 14 of them were selected for gene deletion and further analysis. Results: Transcriptomic analysis revealed a specific gene expression profile in A. baumannii during lung infection with upregulation of genes involved in iron acquisition and host invasion. Mutant strains lacking feoA, mtnN, yfgC, basB, hisF, oatA, and bfnL showed a significant loss of virulence in murine pneumonia. A decrease in biofilm formation, adherence to human epithelial cells, and growth rate was observed in selected mutants. Conclusions: This study provides an insight into A. baumannii gene expression profile during murine pneumonia infection. Data revealed that 7 in vivo upregulated genes were involved in virulence and could be considered new therapeutic targets., This work was supported by Instituto de Salud Carlos III (PI15/00860 and PI18/00501 to G. B. and PI14/00059 and PI17/01482 to A. B. and M. P.); Axencia Galega de Innovacion- Consellería de Economía, Emprego e Industria (IN607A 2016/22 to G. B); Spanish Network for Research in Infectious Diseases and European Development Regional Fund (REIPI RD16/0016/006 and FI18/00315 to J. C. V.-U); M. M.-G. was supported by the Spanish Society of Clinical Microbiology and Infectious Diseases (Clara Roy grant); and K. C.-P. was supported by the Spanish Association Against Cancer.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the Transmission Mechanism between Acinetobacter Genomic Species

  • Lasarte-Monterrubio, Cristina
  • Guijarro, Paula
  • Bellés, Alba
  • Vázquez-Ucha, Juan Carlos
  • Arca-Suárez, Jorge
  • Fernández-Lozano, Carlos
  • Bou, Germán
  • Beceiro Casas, Alejandro
[Abstract] Carbapenem resistance is increasing among Gram-negative bacteria, including the genus Acinetobacter. This study aimed to characterize, for the first time, the development of carbapenem resistance in clinical isolates of Acinetobacter junii and Acinetobacter nosocomialis conferred by the acquisition of a plasmid-borne blaOXA-24/40 gene and also to characterize the dissemination of this gene between species of Acinetobacter. Carbapenem-resistant A. nosocomialis HUAV-AN66 and A. junii HUAV-AJ77 strains were isolated in the Arnau de Vilanova Hospital (Spain). The genomes were sequenced, and in silico analysis were performed to characterize the genetic environment and the OXA-24/40 transmission mechanism. Antibiotic MICs were determined, and horizontal transfer assays were conducted to evaluate interspecies transmission of OXA-24/40. Carbapenems MICs obtained were ≥64 mg/L for HUAV-AN66 and HUAV-AJ77. Genome analysis revealed the presence in both strains of a new plasmid, designated pHUAV/OXA-24/40, harboring the carbapenem-resistance gene blaOXA-24/40 and flanked by sequences XerC/XerD. pHUAV/OXA-24/40 was successfully transferred from A. nosocomialis and A. junii to a carbapenem-susceptible A. baumannii strain, thus conferring carbapenem resistance. A second plasmid (pHUAV/AMG-R) was identified in both clinical isolates for the successful horizontal transfer of pHUAV/OXA-24/40. blaOXA-24/40-carrying plasmids of the GR12 group and showing high identity with pHUAV/OXA-24/40 were identified in at least 8 Acinetobacter species. In conclusion the carbapenemase OXA-24/40 is described for the first time in A. nosocomialis and A. junii. In both isolates the blaOXA-24/40 gene was located in the GR12 pHUAV/OXA-24/40 plasmid. GR12 plasmids are implicated in the dissemination and spread of carbapenem resistance among Acinetobacter species. IMPORTANCE Acinetobacter baumannii is one of the most relevant pathogens in terms of antibiotic resistance. The main resistance mechanisms are the carbapenem-hydrolyzing class D β-lactamases (CHDLs), especially OXA-23 and OXA-24/40. In addition to A. baumannii, there are other species within the genus Acinetobacter, which in general exhibit much lower resistance rates. In this work we characterize for the first time two clinical isolates of Acinetobacter nosocomialis and Acinetobacter junii, isolated in the same hospital, carrying the carbapenemase OXA-24/40 and displaying high resistance rates to carbapenems. By means of bioinformatics analysis we have also been able to characterize the mechanism by which this carbapenemase is horizontally transferred interspecies of Acinetobacter spp. The dissemination of carbapenemase OXA-24/40 between non-baumannii Acinetobacter species is concerning since it prevents the use of most β-lactam antibiotics in the fight against these resistant isolates., This work was supported by Projects PI17/01482 and PI20/01212 awarded to A.B. and PI18/00501 to G.B., all within in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII - General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe.” The work was also supported by CIBERINF (CIBER de Enfermedades Infecciosas). The study was also funded by project IN607A 2020/05 (GAIN- Agencia Gallega de Innovación - Consellería de Economía, Emprego e Industria) awarded to G.B. and IN607D 2021/12 awarded to A.B. This work was also supported by Planes Nacionales de I+D+i2008 to 2011/2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectiosus Diseases (REIPI RD16/0016/006) cofinanced by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth 2014–2020. J.A.-S.was financially supported by the Rio Hortega program (ISCIII, CM19/00219), J.C.V.-U. was financially supported by the pFIS program (ISCIII, PI17/01482), C.L.-M. was financially supported by IN606A-2019/029 Grant (Xunta de Galicia) and P.G.-S. was financially supported by IN607A 2020/05 Grant (Xunta de Galicia), Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12, Xunta de Galicia; IN606A-2019/029
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity

  • Moscoso, Miriam
  • Fuentes-Valverde, Víctor
  • García, Patricia
  • Vallejo, J. A.
  • Pérez-Ortega, Jesús
  • Santamarina-Fernández, Rebeca
  • Candela, Ana
  • Oviaño, Marina
  • Arenas, Jesús
  • Bou, Germán
[Abstract] Introduction: Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen responsible for severe respiratory tract infections. We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 ΔmurI, which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. To reduce the toxicity of PAO1 ΔmurI without compromising its protective efficacy, we engineered strains with a modified lipid A structure, as lipid A is one of the main toxic components of whole-cell vaccines. Methods: Two lipid A-modifying enzymes, LpxR and PagL were overproduced in PAO1 ΔmurI derivatives. The resulting lipopolysaccharide (LPS) was analyzed by MALDI-TOF mass spectrometry. In vitro assays with HEK293-Blue reporter cells expressing murine and human Toll-like receptor 4 (TLR4) were used to assess LPS-associated toxicity, while in vivo reactogenicity and protective efficacy were evaluated in a murine acute pneumonia model. Results: LPS extracted from the wild-type strain showed heterogeneous lipid A structures with varying degrees of acylation, and a predominant penta-acylated species. Expression of LpxR led to enrichment in tetra-acylated species, while PagL expression reduced the heterogeneity observed in the wild type. Both mutant strains showed decreased TLR4 activation in vitro as compared to the wild type. In mice, lipid A-modified derivatives retained protective efficacy; however, no reduction in reactogenicity was observed. Discussion: Lipid A modifications mediated by LpxR and PagL attenuated TLR4 signaling in vitro but were insufficient to reduce in vivo reactogenicity. Additional modifications or targeting of other toxic components may be required. This strategy may serve as an initial basis for optimizing live attenuated P. aeruginosa vaccines, although additional approaches will likely be necessary to achieve substantial improvements., This work was supported by a grant from the SERGAS-Galician Healthcare Service (Program “Innova Saúde”), CIBERINFEC, and the projects PI18/00501 and PI21/00704 to G.B., and the project PI20/00686 to M.O., integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 from the Ministry of Economy and Competitiveness and the Institute of Health Carlos III. In addition, this work was supported by the Ciencia e Innovación/Agencia Española de Investigación MCIN/AEI/10.13039/501100011033 and, as appropriate, by ERDF A way of making Europe by the European Union or by the European Union Next Generation EU/PRTR (Grant agreement PID2020-114617RB-100) to J.A. V.F-V. was funded with a predoctoral fellowship from Conselleria de Cultura, Xunta de Galicia (IN606A-2019/012). A.C. was financially supported by the Río Hortega program (ISCIII-SERGAS, CM21/00165).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin

  • Martínez Guitián, Marta
  • Vázquez-Ucha, Juan Carlos
  • Álvarez-Fraga, Laura
  • Conde-Pérez, Kelly
  • Bou, Germán
  • Poza, Margarita
  • Beceiro Casas, Alejandro
[Abstract] Background: LpxB is an enzyme involved in the biosynthesis pathway of lipid A, a component of LPS. Objectives: To evaluate the lpxB gene in Acinetobacter baumannii as a potential therapeutic target and to propose antisense agents such as peptide nucleic acids (PNAs) as a tool to combat bacterial infection, either alone or in combination with known antimicrobial therapies. Methods: RNA-seq analysis of the A. baumannii ATCC 17978 strain in a murine pneumonia model was performed to study the in vivo expression of lpxB. Protein expression was studied in the presence or absence of anti-lpxB (KFF)3K-PNA (pPNA). Time-kill curve analyses and protection assays of infected A549 cells were performed. The chequerboard technique was used to test for synergy between pPNA and colistin. A Galleria mellonella infection model was used to test the in vivo efficacy of pPNA. Results: The lpxB gene was overexpressed during pneumonia. Treatment with a specific pPNA inhibited LpxB expression in vitro, decreased survival of the ATCC 17978 strain and increased the survival rate of infected A549 cells. Synergy was observed between pPNA and colistin in colistin-susceptible strains. In vivo assays confirmed that a combination treatment of anti-lpxB pPNA and colistin was more effective than colistin in monotherapy. Conclusions: The lpxB gene is essential for A. baumannii survival. Anti-lpxB pPNA inhibits LpxB expression, causing bacterial death. This pPNA showed synergy with colistin and increased the survival rate in G. mellonella. The data suggest that antisense pPNA molecules blocking the lpxB gene could be used as antibacterial agents., This study was funded by projects PI15/00860 and PI18/00501 to G.B., CP13/00226 to A.B., and PI14/00059 and PI17/01482 to A.B. and M.P. (Instituto de Salud Carlos III). The study was also funded by project IN607A 2016/22 (GAIN- Agencia Gallega de Innovación - Consellería de Economía, Emprego e Industria) to G.B. Support was also provided by Planes Nacionales de I + D+i 2013–2016 and ISCIII, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) co-financed by European Development Regional Fund ‘A way to achieve Europe’ and the operative programme Intelligent Growth 2014–2020. J.C.V.U. was financially supported by the Miguel Servet Programme (ISCIII, Spain CP13/00226) and the pFIS Programme (FI18/00315) and M.M.G. was financially supported by a Clara Roy grant (SEIMC) and K.C.P. by IN607A 2016/22.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Selection of AmpC β-Lactamase variants and Metallo-β-Lactamases leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam resistance during treatment of MDR/XDR Pseudomonas aeruginosa infections

  • Ruedas-López, Alba
  • Alonso-García, Isaac
  • Lasarte-Monterrubio, Cristina
  • Guijarro-Sánchez, Paula
  • Gato, Eva
  • Vázquez-Ucha, Juan Carlos
  • Vallejo, J. A.
  • Fraile-Ribot, Pablo Arturo
  • Fernández-Pérez, Begoña
  • Velasco, David
  • Gutiérrez-Urbón, José María
  • Oviaño, Marina
  • Beceiro Casas, Alejandro
  • González-Bello, Concepción
  • Oliver, Antonio
  • Arca-Suárez, Jorge
  • Bou, Germán
[Abstract] Infections caused by ceftolozane-tazobactam and ceftazidime-avibactam-resistant P. aeruginosa infections are an emerging concern. We aimed to analyze the underlying ceftolozane-tazobactam and ceftazidime-avibactam resistance mechanisms in all multidrug-resistant or extensively drug-resistant (MDR/XDR) P. aeruginosa isolates recovered during 1 year (2020) from patients with a documented P. aeruginosa infection. Fifteen isolates showing ceftolozane-tazobactam and ceftazidime-avibactam resistance were evaluated. Clinical conditions, previous positive cultures, and β-lactams received in the previous month were reviewed for each patient. MICs were determined by broth microdilution. Multilocus sequence types (MLSTs) and resistance mechanisms were determined using short- and long-read whole-genome sequencing (WGS). The impact of Pseudomonas-derived cephalosporinases (PDCs) on β-lactam resistance was demonstrated by cloning into an ampC-deficient PAO1 derivative (PAOΔC) and construction of 3D models. Genetic support of acquired β-lactamases was determined in silico from high-quality hybrid assemblies. In most cases, the isolates were recovered after treatment with ceftolozane-tazobactam or ceftazidime-avibactam. Seven isolates from different sequence types (STs) owed their β-lactam resistance to chromosomal mutations and all displayed specific substitutions in PDC: Phe121Leu and Gly222Ser, Pro154Leu, Ala201Thr, Gly214Arg, ΔGly203-Glu219, and Glu219Lys. In the other eight isolates, the ST175 clone was overrepresented (6 isolates) and associated with IMP-28 and IMP-13, whereas two ST1284 isolates produced VIM-2. The cloned PDCs conferred enhanced cephalosporin resistance. The 3D PDC models revealed rearrangements affecting residues involved in cephalosporin hydrolysis. Carbapenemases were chromosomal (VIM-2) or plasmid-borne (IMP-28, IMP-13) and associated with class-1 integrons located in Tn402-like transposition modules. Our findings highlighted that cephalosporin/β-lactamase inhibitors are potential selectors of MDR/XDR P. aeruginosa strains producing PDC variants or metallo-β-lactamases. Judicious use of these agents is encouraged., his work was supported by Projects and PI18/00501 to GB PI17/01482 and PI20/01212 awarded to AB, all within in the National Plan for Scientific Research, Development and Technological Innovation 2013 to 2016 and funded by the ISCIII – General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe”. The study was also funded by project IN607A 2020/05 (GAIN-Agencia Gallega de Innovación – Consellería de Economía, Emprego e Industria) awarded to GB and IN607D 2021/12 awarded to AB. This work was also supported by Planes Nacionales de I+D+i2008 to 2011/2013 to 2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectiosus Diseases (REIPI RD16/0016/006) cofinanced by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth from 2014 to 2020. CGB acknowledges the financial support from the Spanish Ministry of Science and Innovation (PID2019-105512RB-I00), the Xunta de Galicia (ED431C 2021/29) and Centro singular de investigación de Galicia accreditation from 2019 to 2022 (ED431G 2019/03), and the European Regional Development Fund (ERDF). CLM was financially supported by IN606A-2019/029 Grant (Xunta de Galicia) and PGS was financially supported by IN607A 2020/05 Grant (Xunta de Galicia). JCVU was financially supported by the pFIS program (ISCIII, PI17/01482). M.O. was financially supported by the Juan Rodés program (ISCIII-SERGAS, JR18/00006). JAS was financially supported by the Rio Hortega program (ISCIII-SERGAS, CM19/00219).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Diagnostic tool for surveillance, detection and monitoring of the high-risk clone K. pneumoniae ST15

  • Gato, Eva
  • Rodiño-Janeiro, Bruno Kotska
  • Gude, María José
  • Fernández-Cuenca, Felipe
  • Pascual, Álvaro
  • Viña Fernández, Anabel María
  • Pérez Gómez, Astrid
  • Bou, Germán
[Abstract] Background: The global spread of Klebsiella pneumoniae ST15, causing multi-continental outbreaks, contributes to the movement of resistance genes between clones increasing the antimicrobial resistance crisis. The genomic traits providing it with the ability to outcompete other bacteria and cause epidemics remain unclear. Aim: To identify the specific genomic traits of K. pneumoniae ST15 to develop a diagnostic test. Methods: An outbreak caused by K. pneumoniae occurred in Hospital A Coruña, Spain. Antimicrobial susceptibility analysis and molecular typing (PGFE and MLST) were performed. One isolate of each sequence type was selected for whole-genome sequencing analysis. Comparative analysis of genomes was performed using RAST. BLASTn was used to evaluate the presence of the fhaC and kpiD genes. Two hundred and ninety-four K. pneumoniae from a Spanish nationwide collection were analysed by PCR. Findings: Genotyping showed that 87.5% of the isolates tested belonged to a clone with a unique PFGE pattern which corresponded to ST15. Comparative genomic analysis of the different STs enabled us to determine the specific genomic traits of K. pneumoniae ST15. Two adherence-related systems (Kpi and KpFhaB/FhaC) were specific markers of this clone. Multiplex-PCR analysis with kpiD and fhaC oligonucleotides revealed that K. pneumoniae ST15 is specifically detected with a sensitivity of 100% and a specificity of 97.76%. The PCR results showed 100% concordance with the MLST and whole-genome sequencing data. Conclusion: K. pneumoniae ST15 possesses specific genomic traits that could favour its dissemination. They could be used as targets to detect K. pneumoniae ST15 with high sensitivity and specificity., This work was supported by projects PI18/00501 (awarded to G.B.), p-01216A and IJCI-2016-29524 (awarded to A.P.), funded by the Instituto de Salud Carlos III, Spanish Society of Infectious Diseases and Clinical Microbiology and Spanish Ministry of Economy, Industry and Competitiveness (MEIC). A.P. and E.G. are supported by the Miguel Servet (CP22CIII-00007) and Sara Borrel programs, respectively, of the Instituto de Salud Carlos III, Spain., Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica; p-01216A
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections

  • Arca-Suárez, Jorge
  • Lasarte-Monterrubio, Cristina
  • Rodiño-Janeiro, Bruno Kotska
  • Cabot, Gabriel
  • Vázquez-Ucha, Juan Carlos
  • Rodríguez-Iglesias, Manuel
  • Galán-Sánchez, Fátima
  • Beceiro Casas, Alejandro
  • González-Bello, Concepción
  • Oliver, Antonio
  • Bou, Germán
[Abstract] Background: The development of resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of Pseudomonas aeruginosa infections is concerning. Objectives: Characterization of the mechanisms leading to the development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR P. aeruginosa infections. Methods: Four paired ceftolozane/tazobactam- and ceftazidime/avibactam-susceptible/resistant isolates were evaluated. MICs were determined by broth microdilution. STs, resistance mechanisms and genetic context of β-lactamases were determined by genotypic methods, including WGS. The OXA-10 variants were cloned in PAO1 to assess their impact on resistance. Models for the OXA-10 derivatives were constructed to evaluate the structural impact of the amino acid changes. Results: The same XDR ST253 P. aeruginosa clone was detected in all four cases evaluated. All initial isolates showed OprD deficiency, produced an OXA-10 enzyme and were susceptible to ceftazidime, ceftolozane/tazobactam, ceftazidime/avibactam and colistin. During treatment, the isolates developed resistance to all cephalosporins. Comparative genomic analysis revealed that the evolved resistant isolates had acquired mutations in the OXA-10 enzyme: OXA-14 (Gly157Asp), OXA-794 (Trp154Cys), OXA-795 (ΔPhe153-Trp154) and OXA-824 (Asn143Lys). PAO1 transformants producing the evolved OXA-10 derivatives showed enhanced ceftolozane/tazobactam and ceftazidime/avibactam resistance but decreased meropenem MICs in a PAO1 background. Imipenem/relebactam retained activity against all strains. Homology models revealed important changes in regions adjacent to the active site of the OXA-10 enzyme. The blaOXA-10 gene was plasmid borne and acquired due to transposition of Tn6746 in the pHUPM plasmid scaffold. Conclusions: Modification of OXA-10 is a mechanism involved in the in vivo acquisition of resistance to cephalosporin/β-lactamase inhibitor combinations in P. aeruginosa., This work was supported by MSD through the Investigator Initiated Studies Program, which provided financial support and relebactam. This work was also supported by the Ministerio de Economía y Competitividad of Spain, Instituto de Salud Carlos III (ISCIII), through grants PI15/00860 and PI18/00501 to G.B., PI18/00076 to A.O. and P14/00059 and P17/01482 to A.B. Support was also provided by: Planes Nacionales de I + D+i 2013-2016 and ISCIII, Subdireción General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) co-financed by the European Development Regional Fund ‘A way to achieve Europe’; and the operative Intelligent Growth Program 2014-2020. C.G.-B. acknowledges financial support from the Spanish Ministry of Economy and Competiveness (SAF2016-75638-R), the Xunta de Galicia [ED431B 2018/04 and Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03)] and the European Regional Development Fund (ERDF). J.A.-S. was financially supported by the Fundación Profesor Novoa Santos through a Post-Especialización Grant (2019) and by the Rio Hortega Program (ISCIII, CM19/00219). J.C.V.-U. was financially supported by the pFIS Program (ISCIII, PI17/01482). C.L.-M. was financially supported by an IN606A-2019/029 Grant (Xunta de Galicia).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

  • Gato, Eva
  • Guijarro-Sánchez, Paula
  • Alonso-García, Isaac
  • Pedraza-Merino, Rosa
  • Conde, Adrián
  • Lence, Emilio
  • Rumbo-Feal, Soraya
  • Peña-Escolano, Andrea
  • Lasarte-Monterrubio, Cristina
  • Blanco Martín, Tania
  • Fernández González, Ana
  • Fernández-López, María del Carmen
  • Maceiras, Romina
  • Martínez Guitián, Marta
  • Vázquez-Ucha, Juan Carlos
  • Martínez-Martínez, Luis
  • González-Bello, Concepción
  • Arca-Suárez, Jorge
  • Beceiro Casas, Alejandro
  • Bou, Germán
[Abstract] Objectives: In order to inform and anticipate potential strategies aimed at combating KPC-producing Klebsiella pneumoniae infections, we analysed imipenem/relebactam and ceftazidime/avibactam single-step mutant frequencies, resistance development trajectories, differentially selected resistance mechanisms and their associated fitness cost using four representative high-risk K. pneumoniae clones. Methods: Mutant frequencies and mutant preventive concentrations were determined using agar plates containing incremental concentrations of β-lactam/β-lactamase inhibitor. Resistance dynamics were determined through incubation for 7 days in 10 mL MH tubes containing incremental concentrations of each antibiotic combination up to their 64 × baseline MIC. Two colonies per strain from each experiment were characterized by antimicrobial susceptibility testing, whole genome sequencing and competitive growth assays (to determine in vitro fitness). KPC variants associated with imipenem/relebactam resistance were characterized by cloning and biochemical experiments, atomic models and molecular dynamics simulation studies. Results: Imipenem/relebactam prevented the emergence of single-step resistance mutants at lower concentrations than ceftazidime/avibactam. In three of the four strains evaluated, imipenem/relebactam resistance development emerged more rapidly, and in the ST512/KPC-3 clone reached higher levels compared to baseline MICs than for ceftazidime/avibactam. Lineages evolved in the presence of ceftazidime/avibactam showed KPC substitutions associated with high-level ceftazidime/avibactam resistance, increased imipenem/relebactam susceptibility and low fitness costs. Lineages that evolved in the presence of imipenem/relebactam showed OmpK36 disruption, KPC modifications (S106L, N132S, L167R) and strain-specific substitutions associated with imipenem/relebactam resistance and high fitness costs. Imipenem/relebactam-selected KPC derivatives demonstrated enhanced relebactam resistance through important changes affecting relebactam recognition and positioning. Conclusions: Our findings anticipate potential resistance mechanisms affecting imipenem/relebactam during treatment of KPC-producing K. pneumoniae infections., This work was supported by MSD through the Investigator Initiated Studies Program, which provided financial support (to G.B.) and relebactam. This work was also supported by the Fondo de Investigación Sanitaria (grant numbers PI17/01482 and PI20/01212 for A.B. and PI18/00501 and PI21/00704 for G.B.) integrated in the Plan Nacional de I1D and funded by the Instituto de Salud Carlos III (ISCIII), CIBERINFEC (CIBER de Enfermedades Infecciosas). The research was also funded by the Spanish Network of Research in Infectious Diseases (REIPI), no. RD16/0016/0004 and no. RD16/0016/0006, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII–General Subdirection of Assessment and Promotion of the Research—European Regional Development Fund (FEDER) ‘A way of making Europe.’ The study was also funded by GAIN (Agencia Gallega de Innovacion, Conselleria de Economia, Emprego e Industria; IN607D2021/12, A.B. and IN607A 2016/22, G.B.). PGS was financially supported by IN606A-2021/021. I.A.-G was financially supported by the Rio Hortega program (ISCIII, CM21/00076). J.C.V.-U. was financially supported by the ISCIII project FI18/00315. C.L.-M. was financially supported by IN606A-2019/ 029. J.A.-S. was financially supported by the Juan Rodés program (ISCIII, JR21/00026). Financial support from the Spanish Agency of Research (PID2019-105512RB-I00/AEI/10.13039/501100011033, CG-B), the Xunta de Galicia [ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation 2019–2022 (ED431G 2019/03), CG-B], and the European Regional Development Fund (ERDF) is gratefully acknowledged. AC acknowledges Banco Santander for his fellowship. We are also grateful to the Centro de Supercomputación de Galicia (CESGA) for use of the Finis Terrae computer., Xunta de Galicia; IN607D2021/12, Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; IN606A-2021/021, Xunta de Galicia; ED431C 2021/29, Xunta de Galicia; ED431G 2019/03
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Rapid detection of KPC-producing Enterobacterales by using a modified Carba NP test with imipenem/relebactam

  • Oviaño, Marina
  • de la Luna Ramírez, Cecilia
  • González-Bardanca, Mónica
  • Candela, Ana
  • Bou, Germán
Brief report, [Abstract] Introduction: Here, we propose a novel modified Carba NP test for detecting KPC-producing Enterobacterales using imipenem/relebactam. Material and methods: The test performance was evaluated in a random selection of 160 previously molecularly characterized clinical isolates carrying the 110 blaKPC, 1 blaGES, 12 blaVIM, 4 blaIMP, 3 blaNDM and 42 blaOXA-48-like genes. The proposed method relies on the detection of imipenem hydrolysis in an imipenem/relebactam antibiotic solution and subsequent visual interpretation by color change. Results: All class A producing Enterobacterales (111/111) were detected using imipenem/relebactam as no visual appreciation of color change was perceived due to a nule hydrolysis of imipenem in the antibiotic solution. Overall, the assay showed 100% sensitivity (111/111) and specificity (69/69) for detecting class A KPC-producing Enterobacterales. Discussion: The biochemical assay provides very reliable results for detecting KPC-producing Enterobacterales, with a turnaround time of less than 1 hour, minimum handling and no specialized equipment required., [Resumen] Introducción. En este manuscrito proponemos un novedoso ensayo basado en el Carba NP test para la detección de Enterobacterales productoras de KPC utilizando imipenem/relebactam. Material y métodos. La evaluación se realizó en una selección aleatoria de 160 aislados clínicos previamente caracterizados molecularmente que portaban los genes 110 blaKPC, 1 blaGES, 12 blaVIM, 4 blaIMP, 3 blaNDM y 42 blaOXA-48-like. El método propuesto se basa en la detección de la hidrólisis de imipenem en una solución de imipenem/relebactam y posteriormente su interpretación mediante un cambio de color. Resultados. El ensayo tiene una sensibilidad (111/111) y una especificidad (69/69) del 100% para detectar Enterobacterales productoras de KPC, de clase A. Discusión. Este ensayo bioquímico proporciona resultados muy fiables para la detección de Enterobacterales productoras de KPC, con un tiempo de respuesta inferior a 1 h, además de una manipulación mínima y sin necesidad de ningún equipamiento especializado., The results of this work have been funded by the Projects N° PI15/00860 and PI18/00501, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of the Research – European Regional Development Fund (FEDER) “A way of making Europe”.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing

  • Arca-Suárez, Jorge
  • Rodiño-Janeiro, Bruno Kotska
  • Pérez Gómez, Astrid
  • Guijarro-Sánchez, Paula
  • Vázquez-Ucha, Juan Carlos
  • Cruz, Fernando
  • Gómez-Garrido, Jéssica
  • Alioto, Tyler S.
  • Álvarez-Tejado, Miguel
  • Gut, Marta
  • Gut, Ivo
  • Oviaño, Marina
  • Beceiro Casas, Alejandro
  • Bou, Germán
Comparative study, [Abstract] The emergence of 16S rRNA methyltransferases (RMTs) in Gram-negative pathogens bearing other clinically relevant resistance mechanisms, such as carbapenemase-producing Enterobacterales (CPE), is becoming an alarming concern. We investigated the prevalence, antimicrobial susceptibility, resistance mechanisms, molecular epidemiology and genetic support of RMTs in CPE isolates from Spain. This study included a collection of 468 CPE isolates recovered during 2018 from 32 participating Spanish hospitals. MICs were determined using the broth microdilution method, the agar dilution method (fosfomycin) or MIC gradient strips (plazomicin). All isolates were subjected to hybrid whole-genome sequencing (WGS). Sequence types (STs), core genome phylogenetic relatedness, horizontally acquired resistance mechanisms, plasmid analysis and the genetic environment of RMTs were determined in silico from WGS data in all RMT-positive isolates. Among the 468 CPE isolates evaluated, 24 isolates (5.1%) recovered from nine different hospitals spanning five Spanish regions showed resistance to all aminoglycosides and were positive for an RMT (21 RmtF, 2 ArmA and 1 RmtC). All RMT-producers showed high-level resistance to all aminoglycosides, including plazomicin, and in most cases exhibited an extensively drug-resistant susceptibility profile. The RMT-positive isolates showed low genetic diversity and were global clones of Klebsiella pneumoniae (ST147, ST101, ST395) and Enterobacter cloacae (ST93) bearing blaOXA-48, blaNDM-1 or blaVIM-1 carbapenemase genes. RMTs were harboured in five different multidrug resistance plasmids and linked to efficient mobile genetic elements. Our findings highlight that RMTs are emerging among clinical CPE isolates from Spain and their spread should be monitored to preserve the future clinical utility of aminoglycosides and plazomicin., This work was supported by the Ministerio de Economía y Competitividad of Spain, Instituto de Salud Carlos III, through grants PI15/00860 and PI18/00501 to GB and P17/01482 to AB. MG and IG acknowledge the support of the MEIC through the Instituto de Salud Carlos III and the 2014–2020 Smart Growth Operating Program, to the EMBL partnership and co-financing with the European Regional Development Fund [MINECO/FEDER, BIO2015-71792-P]. MG and IG also acknowledge the support of the Centro de Excelencia Severo Ochoa, and the Generalitat de Catalunya through the Departament de Salut, Departament d'Empresa i Coneixement and the CERCA Programme. Support was also provided by Planes Nacionales de I+D+i 2013–2016 and ISCIII, Subdireción General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases [REIPI RD16/0016/006] co-financed by the European Regional Development Fund ‘A Way to Achieve Europe’, and the operative Intelligent Growth program 2014–2020. JAS was financially supported by the Fundacion Profesor Novoa Santos through a Post-especialización grant and by the Rio Hortega program [ISCIII-SERGAS, CM19/00219]. MO was financially supported by the Juan Rodés program [ISCIII-SERGAS, JR18/00006]. JCVU was financially supported by the pFIS program [ISCIII, PI17/01482].
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection

  • Arca-Suárez, Jorge
  • Vázquez-Ucha, Juan Carlos
  • Fraile-Ribot, Pablo Arturo
  • Lence, Emilio
  • Cabot, Gabriel
  • Martínez Guitián, Marta
  • Lasarte-Monterrubio, Cristina
  • Rodríguez-Iglesias, Manuel
  • Beceiro Casas, Alejandro
  • González-Bello, Concepción
  • Galán-Sánchez, Fátima
  • Oliver, Antonio
  • Bou, Germán
[Abstract] Background: Pseudomonas aeruginosa may develop resistance to novel cephalosporin/β-lactamase inhibitor combinations during therapy through the acquisition of structural mutations in AmpC. Objectives: To describe the molecular and biochemical mechanisms involved in the development of resistance to ceftolozane/tazobactam in vivo through the selection and overproduction of a novel AmpC variant, designated PDC-315. Methods: Paired susceptible/resistant isolates obtained before and during ceftolozane/tazobactam treatment were evaluated. MICs were determined by broth microdilution. Mutational changes were investigated through WGS. Characterization of the novel PDC-315 variant was performed through genotypic and biochemical studies. The effects at the molecular level of the Asp245Asn change were analysed by molecular dynamics simulations using Amber. Results: WGS identified mutations leading to modification (Asp245Asn) and overproduction of AmpC. Susceptibility testing revealed that PAOΔC producing PDC-315 displayed increased MICs of ceftolozane/tazobactam, decreased MICs of piperacillin/tazobactam and imipenem and similar susceptibility to ceftazidime/avibactam compared with WT PDCs. The catalytic efficiency of PDC-315 for ceftolozane was 10-fold higher in relation to the WT PDCs, but 3.5- and 5-fold lower for piperacillin and imipenem. IC50 values indicated strong inhibition of PDC-315 by avibactam, but resistance to cloxacillin inhibition. Analysis at the atomic level explained that the particular behaviour of PDC-315 is linked to conformational changes in the H10 helix that favour the approximation of key catalytic residues to the active site. Conclusions: We deciphered the precise mechanisms that led to the in vivo emergence of resistance to ceftolozane/tazobactam in P. aeruginosa through the selection of the novel PDC-315 enzyme. The characterization of this new variant expands our knowledge about AmpC-mediated resistance to cephalosporin/β-lactamase inhibitors in P. aeruginosa., This work was supported by the Ministerio de Economía y Competitividad of Spain, Instituto de Salud Carlos III, through grants PI15/00860 and PI18/00501 to G.B., PI18/00076 to A.O., and P14/00059 and P17/01482 to A.B. Support was also provided by Planes Nacionales de I + D+i 2013–2016 and ISCIII, Subdireción General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) co-financed by the European Development Regional Fund ‘A way to achieve Europe’; and the operative Intelligent Growth program 2014–2020. C.G-B. acknowledges financial support from the Spanish Ministry of Economy and Competiveness (SAF2016-75638-R, C.G-B.), the Xunta de Galicia [ED431B 2018/04 and Centro singular de investigación de Galicia accreditation 2019-2022 (ED431G 2019/03)], and the European Regional Development Fund (ERDF). E.L. thanks the Xunta de Galicia for his postdoctoral fellowship. J.A-S. was financially supported by the Fundación Profesor Novoa Santos through a Post-especialización Grant (2019) and by the Rio Hortega program (ISCIII, CM19/00219). J.C.V-U. was financially supported by the pFIS program (ISCIII, PI17/01482). M.M-G. was financially supported by a Clara Roy grant (SEIMC) and C.L-M. by IN606A-2019/029.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Live Auxotrophic Vaccines Contribute to Protection Against Chronic Lung Infections Caused by Pseudomonas Aeruginosa in C57BL/6 Mice

  • Fuentes-Valverde, Víctor
  • Correia, Alexandra
  • García, Patricia
  • Pérez-Antón, Elena
  • Amorim, Irina
  • Rumbo-Feal, Soraya
  • Cabral, M. P.
  • Vilanova, Manuel
  • Moscoso, Miriam
  • Bou, Germán
[Abstract] Pseudomonas aeruginosa causes severe, often multidrug-resistant lung infections, especially in individuals with cystic fibrosis, highlighting vaccination as a promising preventive approach. This study evaluated intranasal and intradermal immunization with a D-glutamate auxotrophic P. aeruginosa strain (PAO1 ΔmurI) and two of its derivatives, one with additional D-alanine auxotrophy and another exhibiting reduced lipopolysaccharide-associated toxicity, in C57BL/6 mice using both acute and chronic lung infection models. Mice received two or three doses at various intervals, and safety was assessed through clinical and weight monitoring. A high-dose, 2-administration intranasal regimen protected against acute infection but induced transient weight loss, while a lower-dose, 3-administration regimen minimized toxicity. Immunized mice exhibited robust IL-17A production and increased IFN-γ responses. Following challenge with mucoid strains, vaccinated mice showed reduced lung bacterial loads, suggesting a partial protection against chronic infection. These findings support the potential of auxotrophic live vaccines to mitigate disease severity in patients with cystic fibrosis., This work was supported by a grant from the SERGAS-Galician Healthcare Service (Program “Innova Saúde”), CIBERINFEC, La Caixa Foundation -Caixa Capital Risc (CI16-00057), and the projects PI18/00501 and PI21/00704 to GB, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 from the Ministry of Economy and Competitiveness and the Institute of Health Carlos III. VF-V was supported by a predoctoral fellowship from the Conselleria de Cultura, Xunta de Galicia (IN606A-2019/012).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain

  • Vázquez-Ucha, Juan Carlos
  • Alonso-García, Isaac
  • Guijarro-Sánchez, Paula
  • Lasarte-Monterrubio, Cristina
  • Álvarez-Fraga, Laura
  • Cendón-Esteve, Arnau
  • Outeda, Michelle
  • Maceiras, Romina
  • Peña-Escolano, Andrea
  • Martínez Guitián, Marta
  • Arca-Suárez, Jorge
  • Bou, Germán
  • Beceiro Casas, Alejandro
Multicenter study, [Abstract] Metallo-β-lactamase (MBL)-producing Enterobacterales are of particular concern because they are widely disseminated and difficult to treat, being resistant to almost all β-lactam antibiotics. Aztreonam is not hydrolysed by MBLs but is labile to serine β-lactamases (SBLs), which are usually co-produced by MBL-producing Enterobacterales. This study investigated the activity of aztreonam in combination with novel β-lactamase inhibitors (BLIs) against a national multi-centre study collection of strains co-producing MBLs and SBLs. Fifty-five clinical isolates co-producing MBLs (41 VIM producers, 10 NDM producers and 4 IMP producers) and SBLs were selected, and whole-genome sequencing (WGS) was performed. The minimum inhibitory concentration (MIC) values of aztreonam, aztreonam/avibactam, aztreonam/relebactam, aztreonam/zidebactam, aztreonam/taniborbactam, aztreonam/vaborbactam and aztreonam/enmetazobactam were determined. β-lactam/BLI resistance mechanisms were analysed by WGS. All BLIs decreased the MIC values of aztreonam for strains that were not susceptible to aztreonam. Aztreonam/zidebactam (MIC ≤1 mg/L for 96.4% of isolates), aztreonam/avibactam (MIC ≤1 mg/L for 92.7% of isolates) and aztreonam/taniborbactam (MIC ≤1 mg/L for 87.3 % of isolates) were the most active combinations. For other aztreonam/BLI combinations, 50-70% of the isolates yielded MIC values ≤1 mg/L. WGS data revealed that mutations in PBP3, defective OmpE35/OmpK35 porins, and the presence of extended-spectrum β-lactamases and class C β-lactamases were some of the resistance mechanisms involved in reduced susceptibility to aztreonam/BLIs. Combinations of aztreonam with new BLIs show promising activity against Enterobacterales co-producing MBLs and SBLs, particularly aztreonam/zidebactam, aztreonam/avibactam and aztreonam/taniborbactam. The present results show that these novel drugs may represent innovative therapeutic strategies by their use in yet-unexplored combinations as solutions for difficult-to-treat infections., This study was funded by Instituto de Salud Carlos III (ISCIII) through Projects N° Exp PI20/01212 and PI18/00501, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2017-2020, and co-funded by European Union – European Regional Development Fund ‘A way to make Europe’. The work was also supported by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB21/13/00055), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU. In addition, the study was funded by Project IN607A 2020/05 (Agencia Gallega de Innovación – Consellería de Economía, Emprego e Industria) awarded to GB, and Project IN607D 2021/12 awarded to AB. The work was also supported by Planes Nacionales de I+D+i 2017-2020 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006), co-financed by European Development Regional Fund ‘A way to achieve Europe’ and operative programme Intelligent Growth 2014-2020. JA-S was financially supported by the Juan Rodés programme (ISCIII, JR21/00026), JCV-U was financially supported by IN606B-2022/009 (Xunta de Galicia), CL-M was financially supported by IN606A-2019/029 (Xunta de Galicia) and PI20/01212 (ISCIII), and PG-S was financially supported by IN606A 2021/021 (Xunta de Galicia). AC and MO were financially supported by IN607D 2021/12. IA-G was financially supported by the Río Hortega programme (ISCIII, CM21/00076). LA-F was financially supported by IN606B- 2018/011 (Xunta de Galicia). MM-G was financially supported by RSU.UDC.M505 (Ministerio de Universidades)., Xunta de Galicia; IN606B-2022/009, Xunta de Galicia; IN606A-2019/029, Xunta de Galicia; IN606A 2021/021, Xunta de Galicia; IN606B- 2018/011, Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Challenging antimicrobial susceptibility and evolution of resistance (oxa-681) during treatment of a long-term nosocomial infection caused by a pseudomonas aeruginosa ST175 Clone

  • Arca-Suárez, Jorge
  • Fraile-Ribot, Pablo Arturo
  • Vázquez-Ucha, Juan Carlos
  • Cabot, Gabriel
  • Martínez Guitián, Marta
  • Lence, Emilio
  • González-Bello, Concepción
  • Beceiro Casas, Alejandro
  • Rodríguez-Iglesias, Manuel
  • Galán, Fátima
  • Bou, Germán
  • Oliver, Antonio
Case report, [Abstract] Selection of extended-spectrum mutations in narrow-spectrum oxacillinases (e.g., OXA-2 and OXA-10) is an emerging mechanism for development of in vivo resistance to ceftolozane-tazobactam and ceftazidime-avibactam in Pseudomonas aeruginosa Detection of these challenging enzymes therefore seems essential to prevent clinical failure, but the complex phenotypic plasticity exhibited by this species may often lead to their underestimation. The underlying resistance mechanisms of two sequence type 175 (ST175) P. aeruginosa isolates showing multidrug-resistant phenotypes and recovered at early and late stages of a long-term nosocomial infection were evaluated. Whole-genome sequencing (WGS) was used to investigate resistance genomics, whereas molecular and biochemical methods were used for characterization of a novel extended-spectrum OXA-2 variant selected during therapy. The metallo-β-lactamase blaVIM-20 and the narrow-spectrum oxacillinase blaOXA-2 were present in both isolates, although they differed by an inactivating mutation in the mexB subunit, present only in the early isolate, and in a mutation in the blaOXA-2 β-lactamase, present only in the final isolate. The new OXA-2 variant, designated OXA-681, conferred elevated MICs of the novel cephalosporin-β-lactamase inhibitor combinations in a PAO1 background. Compared to OXA-2, kinetic parameters of the OXA-681 enzyme revealed a substantial increase in the hydrolysis of cephalosporins, including ceftolozane. We describe the emergence of the novel variant OXA-681 during treatment of a nosocomial infection caused by a Pseudomonas aeruginosa ST175 high-risk clone. The ability of OXA-681 to confer cross-resistance to ceftolozane-tazobactam and ceftazidime-avibactam together with the complex antimicrobial resistance profiles exhibited by the clinical strains harboring this new enzyme argue for maintaining active surveillance on emerging broad-spectrum resistance in P. aeruginosa., This work was supported by the Ministerio de Economía y Competitividad of Spain, Instituto de Salud Carlos III, through grants PI1800076 to A.O., PI15/00860 and PI18/00501 to G.B., and P14/00059 and P17/01482 to A.B. and through grants from the Spanish Ministry of Economy and Competitiveness (SAF2016-75638-R) and the Xunta de Galicia (ED431G/09) to C.G.-B. This work was also supported by the European Regional Development Fund A Way To Achieve Europe ERDF, through the Spanish Network for Research in Infectious Diseases (RD16/0016). J.C.V.-U. was financially supported by the pFIS program (ISCIII, PI17/01482), and M.M.-G. was financially supported by a Clara Roy grant (SEIMC).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections

  • Alonso-García, Isaac
  • Vázquez-Ucha, Juan Carlos
  • Lasarte-Monterrubio, Cristina
  • González-Mayo, Elena
  • Lada-Salvador, Paula
  • Vela-Fernández, Ramón
  • Aja-Macaya, Pablo
  • Guijarro-Sánchez, Paula
  • Rumbo-Feal, Soraya
  • Muíño-Andrade, María José
  • Fernández González, Ana
  • Martínez Guitián, Marta
  • Beceiro Casas, Alejandro
  • Rodríguez-Iglesias, Manuel
  • Oliver, Antonio
  • Arca-Suárez, Jorge
  • Galán-Sánchez, Fátima
  • Bou, Germán
[Abstract] Objectives: To describe and characterize the emergence of resistance to ceftolozane/tazobactam, ceftazidime/avibactam and imipenem/relebactam in a patient receiving ceftazidime/avibactam treatment for an MDR Pseudomonas aeruginosa CNS infection. Methods: One baseline (PA1) and two post-exposure (PA2 and PA3) isolates obtained before and during treatment of a nosocomial P. aeruginosa meningoventriculitis were evaluated. MICs were determined by broth microdilution. Mutational changes were investigated through WGS. The impact on β-lactam resistance of mutations in blaPDC and mexR was determined through cloning experiments and complementation assays. Results: Isolate PA1 showed baseline resistance mutations in DacB (I354A) and OprD (N142fs) conferring resistance to conventional antipseudomonals but susceptibility to ceftazidime/avibactam, ceftolozane/tazobactam and imipenem/relebactam. Post-exposure isolates showed two divergent ceftazidime/avibactam-resistant phenotypes associated with distinctive mutations affecting the intrinsic P PDC β-lactamase (S254Ins) (PA2: ceftolozane/tazobactam and ceftazidime/avibactam-resistant) or MexAB-OprM negative regulator MexR in combination with modification of PBP3 (PA3: ceftazidime/avibactam and imipenem/relebactam-relebactam-resistant). Cloning experiments demonstrated the role of PDC modification in resistance to ceftolozane/tazobactam and ceftazidime/avibactam. Complementation with a functional copy of the mexR gene in isolate PA3 restored imipenem/relebactam susceptibility. Conclusions: We demonstrated how P. aeruginosa may simultaneously develop resistance and compromise the activity of new β-lactam/β-lactamase inhibitor combinations when exposed to ceftazidime/avibactam through selection of mutations leading to PDC modification and up-regulation of MexAB-OprM-mediated efflux., This work was supported by the Fondo de Investigación Sanitaria (grant numbers PI22/01212 for J.A.-S., PI17/01482 and PI20/01212 for A.B., PI21/00017 for A.O., and PI18/00501 and PI21/00704 for G.B. integrated in the Plan Nacional de I1D and funded by the Instituto de Salud Carlos III, ISCIII). This research was also funded by CIBERINFEC, no. CB21/13/00055 and no. CB21/13/00099 (CIBER de Enfermedades Infecciosas), and by the Spanish Network of Research in Infectious Diseases (REIPI), no. RD16/0016/0004 and no. RD16/0016/0006, integrated in the National Plan for Scientific Research, Development and Technological Innovation 2013–2016 and funded by the ISCIII–General Subdirection of Assessment and Promotion of the Research–European Regional Development Fund (FEDER) ‘A way of making Europe’. The study was also funded by GAIN (Agencia Gallega de Innovacion, Conselleria de Economia, Emprego e Industria; IN607D2021/12 to A.B. and IN607A 2016/22 to G.B.). I.A.-G was financially supported by the Rio Hortega programme (ISCIII, CM21/00076). J.C.V.-U. was financially supported by the ISCIII project FI18/00315. C.L.-M. was financially supported by IN606A-2019/029. J.A.-S. was financially supported by the Juan Rodés program (ISCIII, JR21/00026)., Xunta de Galicia; IN607D2021/12, Xunta de Galicia; IN607A 2016/22
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae

  • Poza, Margarita
  • Vázquez-Ucha, Juan Carlos
  • Martínez Guitián, Marta
  • Lasarte-Monterrubio, Cristina
  • Conde-Pérez, Kelly
  • Arca-Suárez, Jorge
  • Álvarez-Fraga, Laura
  • Pérez Gómez, Astrid
  • Crecente-Campo, José
  • Alonso, María J.
  • Bou, Germán
  • Beceiro Casas, Alejandro
[Abstract] The discovery of new antibiotics that are effective against Acinetobacter baumannii and Enterobacteralesis a research priority. Several essential oils (EOs) have displayed some antimicrobial activity and could potentially act as antibiotic adjuvants. Research in this area aims to develop new therapeutic alternatives to treat infections caused by these pathogens. MICs of different EOs were determined against A. baumannii and Klebsiella pneumoniae. Combined disk diffusion tests and checkerboard assays were used to study the synergy between the EOs and antibiotics. The fractional inhibitory concentration index (FICindex) was calculated in order to categorize the interaction. Time-kill assays were also performed. The EOs that displayed the highest levels of antimicrobial activity were clove (Syzygium aromaticum L.) and thyme (Thymus zygis L.). Combined disk diffusion tests and checkerboard assays revealed synergy between these EOs and colistin. Addition of either clove or thyme EO decreased the MIC of colistin by 8- to 64-fold and 8- to 128-fold in the colistin-resistant A. baumannii and K. pneumoniae strains, respectively (FICindex ≤ 0.5, synergy). MICs were also reduced in the colistin-susceptible strains. Time-kill assays also indicated the strong activity of the combined therapy. In summary, the use of clove or thyme EO in combination with colistin could improve the efficacy of the antibiotic and significantly reduce the concentrations needed to inhibit growth of A. baumannii and K. pneumoniae., Funding: This study was funded by projects IN607A 2016/22 (GAIN), PI15/00860, PI18/00501 and REIPI RD16/0016/006 (co-financed by the European Development Regional Fund "A way to achieve Europe" and the operative Intelligent Growth program 2014-2020) awarded to GB, PI14/00059 and PI17/01482 awarded to AB and MP (Instituto de Salud Carlos III). JCVU was financially supported the pFIS Programme (FI18/00315, ISCIII), MMG by a Clara Roy grant (SEIMC), KCP by IN607A 2016/22 (GAIN), CLM by IN606A-2019/029 (GAIN) and JAS by the Rio Hortega program (CM19/00219, ISCIII) and the FPNS (post-specialization grant). Acknowledgements: We thank Dr J.D. Boyce for the kind gift of ATCC19606ΔlpxC. We also thank Dr S. Pournaras for the kind gift of AB248 and AB249.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Engineering and evaluation of a live-attenuated vaccine candidate with enhanced Type 1 fimbriae expression to optimize protection against Salmonella Typhimurium

  • García, Patricia
  • Rodríguez-Coello, Arianna
  • García-Pose, Andrea
  • Fernández-López, María del Carmen
  • Muras, Andrea
  • Moscoso, Miriam
  • Beceiro Casas, Alejandro
  • Bou, Germán
[Abstract] Background:Salmonella Typhimurium is a major zoonotic pathogen, in which type 1 fimbriae play a crucial role in intestinal colonization and immune modulation. This study aimed to improve the protective immunity of a previously developed growth-deficient strain-a double auxotroph for D-glutamate and D-alanine-by engineering the inducible expression of type 1 fimbriae. Methods: PtetA-driven expression of the fim operon was achieved by λ-Red mutagenesis. fimA expression was quantified by qRT-PCR, and fimbriation visualized by transmission electron microscopy. Adhesive properties were evaluated through FimH sequence analysis, yeast agglutination, mannose-binding/inhibition assays, and HT-29 cell adherence. BALB/c mice were immunized orogastrically with IRTA ΔΔΔ or IRTA ΔΔΔ PtetA::fim. Safety and immunogenicity were assessed by clinical monitoring, bacterial load, fecal shedding, ELISA tests, and adhesion/blocking assays using fecal extracts. Protection was evaluated after challenging with wild-type and heterologous strains. Results: IRTA ΔΔΔ PtetA::fim showed robust fimA expression, dense fimbrial coverage, a marked mannose-sensitive adhesive phenotype and enhanced HT-29 attachment. Fimbrial overexpression did not alter intestinal colonization or translocation to mesenteric lymph nodes (mLNs). Immunization elicited a mixed IgG1/IgG2a, significantly increased IgA and IgG against type 1 fimbriae-expressing Salmonella, and enhanced the ability of fecal extracts to inhibit the adherence of wild-type strains. Upon challenge (IRTA wild-type/20220258), IRTA ΔΔΔ PtetA::fim reduced infection burden in the cecum (-1.46/1.47-log), large intestine (-1.35/2.17-log), mLNs (-1.32/0.98-log) and systemic organs more effectively than IRTA ΔΔΔ. Conclusions: Inducible expression of type 1 fimbriae enhances mucosal immunity and protection, supporting their inclusion in next-generation Salmonella vaccines. Future work should assess cross-protection and optimize FimH-mediated targeting for mucosal delivery., This study was supported by a grant from SERGAS (The Galician Healthcare Service) (Programs “InnovaSaude” and “InnovaMicrolab”), the Spanish Network for Research in Infectious Diseases (RD16/0016/0006), CIBER-Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (CB21/13/00055), project PI18/00501, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (ERDF/ESF, “A way to make Europe”/”Investing in your future”) and PI21/00704, funded by ISCIII and co-funded by the European Union, awarded to GB. This research was also supported by Projects PI20/01212 and PI23/00851 awarded to A.B., funded by ISCIII and co-funded by the European Union, and by project IN607D 2021/12 awarded to A.B., funded by GAIN-Agencia Gallega de Innovación, Consellería de Economía, Emprego e Industria. A.R was supported by a predoctoral fellowship from the Instituto de Salud Carlos III (FI24/00178). A.M. was supported by a postdoctoral fellowship from the Instituto de Salud Carlos III (CD23/00057).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Antimicrobial activity of Cefiderocol against the Carbapenemase-producing Enterobacter cloacae complex and characterization of reduced susceptibility associated with Metallo-β-Lactamase VIM-1

  • Lasarte-Monterrubio, Cristina
  • Guijarro-Sánchez, Paula
  • Vázquez-Ucha, Juan Carlos
  • Alonso-García, Isaac
  • Álvarez-Fraga, Laura
  • Outeda-García, Michelle
  • Martínez Guitián, Marta
  • Peña-Escolano, Andrea
  • Maceira, Romina
  • Lence, Emilio
  • González-Bello, Concepción
  • Arca-Suárez, Jorge
  • Bou, Germán
  • Beceiro Casas, Alejandro
[Abstract] Emergence of cefiderocol resistance among carbapenemase-producing Enterobacterales, particularly those in the Enterobacter cloacae complex (ECC), is becoming of alarming concern; however, the mechanistic basis of this phenomenon remains poorly understood. We describe the acquisition of VIM-1-mediated reduced cefiderocol susceptibility (MICs 0.5 to 4 mg/L) in a collection of 54 carbapenemase-producing isolates belonging to the ECC. MICs were determined by reference methodologies. Antimicrobial resistance genomic analysis was performed through hybrid WGS. The impact of VIM-1 production on cefiderocol resistance in the ECC background was examined at microbiological, molecular, biochemical, and atomic levels. Antimicrobial susceptibility testing yielded 83.3% susceptible isolates and MIC50/90 values of 1/4 mg/L. Decreased susceptibility to cefiderocol was mainly associated with isolates producing VIM-1, with cefiderocol MICs 2- to 4-fold higher than for isolates carrying other types of carbapenemases. E. cloacae and Escherichia coli VIM-1 transformants displayed significantly enhanced cefiderocol MICs. Biochemical assays with purified VIM-1 protein revealed low but detectable cefiderocol hydrolysis. Simulation studies revealed how cefiderocol is anchored to the VIM-1 active site. Additional molecular assays and WGS data analysis highlighted the implication of SHV-12 coproduction and suggested the inactivation of the FcuA-like siderophore receptor as further contributors to the higher cefiderocol MICs. Our findings warn of the potential of the VIM-1 carbapenemase to at least partly limit the activity of cefiderocol in the ECC. This effect is probably enhanced due to combination with additional mechanisms, such as ESBL production and siderophore inactivation, and indicates the need for active surveillance to extend the life span of this promising cephalosporin., This research was supported by Projects PI17/01482 and PI20/01212 awarded to AB, PI22/01212 to JAS and PI18/00501 to GB, within in the National Plan for Scientific Research, Development and Technological Innovation 2017 to 2020 and funded by the ISCIII-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) “A way of making Europe.” The work was also supported by CIBERINFEC (CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III). The study was also funded by project IN607A 2020/05 (GAIN-Agencia Gallega de Innovación-Consellería de Economía, Emprego e Industria) awarded to GB and project IN607D 2021/12 awarded to AB. It was also supported by Planes Nacionales de I+D+i2017 to 2020 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) cofinanced by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth2014 to 2020. J.A.-S. was financially supported by the Juan Rodés program (ISCIII, JR21/00026), J.C.V.-U. was financially supported by IN606B-2022/009 Grant (Xunta de Galicia), C.L.-M. was financially supported by IN606A-2019/029 Grant (Xunta de Galicia) and PGS was financially supported by IN606A 2021/021 Grant (Xunta de Galicia). M.O. was financially supported by IN607D 2021/12 (Xunta de Galicia). I.A.-G. was financially supported by the Rio Hortega program (ISCIII, CM21/00076). C.G.-B. acknowledges financial support from the Spanish Ministry of Science and Innovation (PID2019-105512RB-I00), the Xunta de Galicia (ED431C 2021/29 and the Centro singular de investigación de Galicia accreditation2019 to 2022 [ED431G 2019/03]), and the European Regional Development Fund (ERDF)., Xunta de Galicia; IN607A 2020/05, Xunta de Galicia; IN607D 2021/12, Xunta de Galicia; IN606B-2022/009, Xunta de Galicia; IN606A-2019/029, Xunta de Galicia; IN606A 2021/021, Xunta de Galicia; ED431C 2021/29, Xunta de Galicia; ED431G 2019/03
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Marine Organisms from the Yucatan Peninsula (Mexico) as a Potential Natural Source of Antibacterial Compounds

  • Pech-Puch, Dawrin
  • Pérez Povedano, Mar Anabel
  • Gómez, Patricia
  • Martínez Guitián, Marta
  • Lasarte-Monterrubio, Cristina
  • Vázquez-Ucha, Juan Carlos
  • Novoa Olmedo, María Lourdes
  • Guillén-Hernández, Sergio
  • Villegas-Hernández, Harold
  • Bou, Germán
  • Rodríguez, Jaime
  • Beceiro Casas, Alejandro
  • Jiménez, Carlos
[Abstract] A total of 51 sponges (Porifera) and 13 ascidians (Chordata) were collected on the coast of the Yucatan Peninsula (Mexico) and extracted with organic solvents. The resulting extracts were screened for antibacterial activity against four multidrug-resistant (MDR) bacterial pathogens: the Gram-negative Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa and the Gram-positive Staphylococcus aureus. The minimum inhibitory concentrations (MICs) of the organic extracts of each marine organism were determined using a broth microdilution assay. Extracts of eight of the species, in particular the Agelas citrina and Haliclona (Rhizoniera) curacaoensis, displayed activity against some of the pathogens tested. Some of the extracts showed similar MIC values to known antibiotics such as penicillins and aminoglycosides. This study is the first to carry out antimicrobial screening of extracts of marine sponges and ascidians collected from the Yucatan Peninsula. Bioassay-guided fractionation of the active extracts from the sponges Amphimedon compressa and A. citrina displayed, as a preliminary result, that an inseparable mixture of halitoxins and amphitoxins and (-)-agelasine B, respectively, are the major compounds responsible for their corresponding antibacterial activities. This is the first report of the antimicrobial activity of halitoxins and amphitoxins against major multidrug-resistant human pathogens. The promising antibacterial activities detected in this study indicate the coast of Yucatan Peninsula as a potential source of a great variety of marine organisms worthy of further research., This work was supported by Grants RTI2018-093634-B-C22 (AEI/FEDER, EU) from the State Agency for Research (AEI) of Spain, co-funded by the FEDER Programme from the European Union, by projects PI15/00860 and PI18/00501 to GB and PI14/00059 and PI17/01482 to AB (Instituto de Salud Carlos III) and BLUEBIOLAB (0474_BLUEBIOLAB_1_E), Programme INTERREG V A of Spain-Portugal (POCTEP). The study was also funded by projects IN607A 2016/22 (GAIN- Agencia Gallega de Innovación - Consellería de Economía, Emprego e Industria) and GRC2018/039 and Agrupación Estratégica CICA-INIBIC ED431E 2018/03 (Consellería de Educación, Universidades e Formación Profesional) from the Xunta de Galicia (autonomous government of the region). Support was also provided by Planes Nacionales de I+D+i 2013-2016 and ISCIII, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) co-financed by European Development Regional Fund "A way to achieve Europe" and the operative program Intelligent Growth 2014-2020. J.C.V.U. was financially supported by the pFIS Programme (FI18/00315), M.M.G. was financially supported by a Clara Roy grant (SEIMC) and C.L.M. by IN606A-2019/029. D.P.P. received a fellowship from the program National Council of Science and Technology (CONACYT) of Mexico and the Secretariat of Research, Innovation and Higher Education (SIIES) of Yucatan (Mexico), Xunta de Galicia; IN607A 2016/22, Xunta de Galicia; GRC2018/039, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN606A-2019/029
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Kpi, a Chaperone-Usher Pili System Associated with the Worldwide-Disseminated High-Risk Clone Klebsiella Pneumoniae ST-15

  • Gato, Eva
  • Vázquez-Ucha, Juan Carlos
  • Rumbo-Feal, Soraya
  • Álvarez-Fraga, Laura
  • Vallejo, J. A.
  • Martínez Guitián, Marta
  • Beceiro Casas, Alejandro
  • Ramos Vivas, Jose
  • Sola-Campoy, Pedro Juan
  • Pérez-Vázquez, María
  • Oteo, Jesús
  • Rodiño-Janeiro, Bruno Kotska
  • Romero, A.
  • Poza, Margarita
  • Bou, Germán
  • Pérez Gómez, Astrid
[Abstract] Control of infections caused by carbapenem-resistant Klebsiella pneumoniae continues to be challenging. The success of this pathogen is favored by its ability to acquire antimicrobial resistance and to spread and persist in both the environment and in humans. The emergence of clinically important clones, such as sequence types 11, 15, 101, and 258, has been reported worldwide. However, the mechanisms promoting the dissemination of such high-risk clones are unknown. Unraveling the factors that play a role in the pathobiology and epidemicity of K. pneumoniae is therefore important for managing infections. To address this issue, we studied a carbapenem-resistant ST-15 K. pneumoniae isolate (Kp3380) that displayed a remarkable adherent phenotype with abundant pilus-like structures. Genome sequencing enabled us to identify a chaperone-usher pili system (Kpi) in Kp3380. Analysis of a large K. pneumoniae population from 32 European countries showed that the Kpi system is associated with the ST-15 clone. Phylogenetic analysis of the operon revealed that Kpi belongs to the little-characterized γ2-fimbrial clade. We demonstrate that Kpi contributes positively to the ability of K. pneumoniae to form biofilms and adhere to different host tissues. Moreover, the in vivo intestinal colonizing capacity of the Kpi-defective mutant was significantly reduced, as was its ability to infect Galleria mellonella. The findings provide information about the pathobiology and epidemicity of Kpi+ K. pneumoniae and indicate that the presence of Kpi may explain the success of the ST-15 clone. Disrupting bacterial adherence to the intestinal surface could potentially target gastrointestinal colonization., This research was supported by Projects p-01216A and IJCI-2016-29524 (to A.P.), funded by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Minestry of Economy and Competetiveness (MINECO), respectively. It was also supported by Projects PI11/01034 (to M.P.), PI14/00059 and PI17/1482 (to M.P. and A.B.), and PI18/00501 (to G.B.), included in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 and funded by the Instituto de Salud Carlos III (ISCIII) and Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) cofinanced by European Development Regional Fund “A way to achieve Europe” and operative program Intelligent Growth 2014-2020. Grant BFU2016-77835-R of the MINECO (to A.R.) also supported this research. E.G. was financially supported by the SEIMC project. J.C.V.-U. was financially supported by the PFIS (Contratos Predoctorales de Formación en Investigación en Salud) program (F18/00315); J.A.V. was financially supported by IN607A 2016/22; M.M.-G. was financially supported by a Clara Roy grant (SEIMC); A.B. was financially supported by the Miguel Servet program (ISCIII, Spain); B.K.R.-J. was financially supported by Marie S. Curie Action SaPhaDe project (MSCA-IF-GF-836754); and A.P. was financially supported by the Juan de la Cierva program (MINECO, IJCI-2016-29524), Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica; p-01216A, Xunta de Galicia; IN607A 2016/22
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Diagnostic tool for surveillance, detection and monitoring of the high-risk clone K. pneumoniae ST15

  • Gato, Eva
  • Rodiño-Janeiro, Bruno Kotska
  • Gude, María José
  • Fernández-Cuenca, Felipe
  • Pascual, Álvaro
  • Fernández, Anabel María Viña
  • Pérez, A.
  • Bou, Germán
[Background] The global spread of Klebsiella pneumoniae ST15, causing multi-continental outbreaks, contributes to the movement of resistance genes between clones increasing the antimicrobial resistance crisis. The genomic traits providing it with the ability to outcompete other bacteria and cause epidemics remain unclear., [Aim] To identify the specific genomic traits of K. pneumoniae ST15 to develop a diagnostic test., [Methods] An outbreak caused by K. pneumoniae occurred in Hospital A Coruña, Spain. Antimicrobial susceptibility analysis and molecular typing (PGFE and MLST) were performed. One isolate of each sequence type was selected for whole-genome sequencing analysis. Comparative analysis of genomes was performed using RAST. BLASTn was used to evaluate the presence of the fhaC and kpiD genes. Two hundred and ninety-four K. pneumoniae from a Spanish nationwide collection were analysed by PCR., [Findings] Genotyping showed that 87.5% of the isolates tested belonged to a clone with a unique PFGE pattern which corresponded to ST15. Comparative genomic analysis of the different STs enabled us to determine the specific genomic traits of K. pneumoniae ST15. Two adherence-related systems (Kpi and KpFhaB/FhaC) were specific markers of this clone. Multiplex-PCR analysis with kpiD and fhaC oligonucleotides revealed that K. pneumoniae ST15 is specifically detected with a sensitivity of 100% and a specificity of 97.76%. The PCR results showed 100% concordance with the MLST and whole-genome sequencing data., [Conclusion] K. pneumoniae ST15 possesses specific genomic traits that could favour its dissemination. They could be used as targets to detect K. pneumoniae ST15 with high sensitivity and specificity., This work was supported by projects PI18/00501 (awarded to G.B.), p-01216A and IJCI-2016-29524 (awarded to A.P.), funded by the Instituto de Salud Carlos III, Spanish Society of Infectious Diseases and Clinical Microbiology and Spanish Ministry of Economy, Industry and Competitiveness (MEIC). A.P. and E.G. are supported by the Miguel Servet (CP22CIII-00007) and Sara Borrel programs, respectively, of the Instituto de Salud Carlos III, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap

  • Álvarez-Bustos, Alejandro
  • Andrés-Lacueva, Cristina
  • Ara, Ignacio
  • Arévalo, María Ángeles
  • Bolaños, Juan P.
  • Coto, Ana
  • Enríquez, José Antonio
  • Escames, Germaine
  • García-García, Francisco José
  • Gómez-Cabrera, Mari Carmen
  • Grau, Oriol
  • Izquierdo, Mikel
  • Martínez Velilla, Nicolás
  • Matheu, Ander
  • Menéndez Colino, Rocío
  • Muñoz Torres, Manuel
  • Nogués, Xavier
  • Oliva, Juan
  • Orts-Cortés, María Isabel
  • Párraga Martínez, Ignacio
  • Priego, Feliciano
  • Rabassa, Montserrat
  • Rol, María Ángeles
  • Serra-Rexach, José Antonio
  • Tarazona-Santabalbina, Francisco José
  • Rodríguez-Mañas, Leocadio
  • Abizanda, Pedro
The lack of a universally accepted definition, a gold-standard assessment tool, and sufficient evidence-based interventions has hindered the integration of frailty into routine clinical practice, particularly outside geriatric medicine. For clinicians, health professionals, policymakers, and aging researchers, a unified framework based on robust evidence has become essential., The present study received funding from the projects CB16/10/00408, CB16/10/00269, CB16/10/00477, CB16/10/00383, CB16/10/00282, CB16/10/00289, CB16/10/00238, CB16/10/00456, CB16/10/00435, CB16/10/00417, CB16/10/00315, CB16/10/00496, CB16/10/00468, CB16/10/00475, CB16/10/00245, CB23/10/00037, CB16/10/00501, CB16/10/00464, CB16/10/00239, CB16/10/00314, Instituto de Salud Carlos III, Madrid, Spain., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model

  • Perez-Estenaga, Iñigo
  • Chevalier, Merari Tumin
  • Peña, Estefania
  • Abizanda, Gloria
  • Alsharabasy, Amir M.
  • Larequi, Eduardo
  • Cilla, Myriam
  • Perez, Marta M.
  • Gurtubay, Jon
  • Garcia-Yebenes Castro, Manuel
  • Prosper, Felipe
  • Pandit, Abhay
  • Pelacho, Beatriz
Ischemic heart disease is one of the leading causes of death worldwide. The efficient delivery of therapeutic growth factors could counteract the adverse prognosis of post-myocardial infarction (post-MI). In this study, a collagen hydrogel that is able to load and appropriately deliver pro-angiogenic stromal cell-derived factor 1 (SDF1) was physically coupled with a compact collagen membrane in order to provide the suture strength required for surgical implantation. This bilayer collagen-on-collagen scaffold (bCS) showed the suitable physicochemical properties that are needed for efficient implantation, and the scaffold was able to deliver therapeutic growth factors after MI. In vitro collagen matrix biodegradation led to a sustained SDF1 release and a lack of cytotoxicity in the relevant cell cultures. In vivo intervention in a rat subacute MI model resulted in the full integration of the scaffold into the heart after implantation and biocompatibility with the tissue, with a prevalence of anti-inflammatory and pro-angiogenic macrophages, as well as evidence of revascularization and improved cardiac function after 60 days. Moreover, the beneficial effect of the released SDF1 on heart remodeling was confirmed by a significant reduction in cardiac tissue stiffness. Our findings demonstrate that this multimodal scaffold is a desirable matrix that can be used as a drug delivery system and a scaffolding material to promote functional recovery after MI.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Engineering low-endotoxin lipid A in a double auxotroph Pseudomonas aeruginosa to develop safer whole-cell vaccines

  • Fuentes-Valverde, Víctor
  • García, Patricia
  • Candela, Ana
  • Santamarina-Fernández, Rebeca
  • Avendaño-Ortiz, José
  • Martínez-Alonso, Emma
  • Oviaño, Marina
  • Cantón, Rafael
  • Arenas, Jesús
  • Moscoso, Miriam
  • Bou, Germán
Introduction: Pseudomonas aeruginosa is a highly adaptable Gram-negative bacterium causing severe respiratory infections, particularly in vulnerable populations. The rise of antimicrobial resistance highlights the urgent need for effective vaccines. We previously developed a live-attenuated vaccine candidate, PAO1 ΔmurI Δalr ΔdadX, a genetically stable double auxotrophic strain that exhibited dose-dependent reactogenicity upon intranasal administration in mice, likely due to lipid A component of lipopolysaccharide (LPS). Methods: To reduce LPS-associated toxicity while preserving immunogenicity, we engineered novel strains by inactivating genes involved in lipid A biosynthesis (htrB1, htrB2) or modification (pagP, pagL). Lipid A structural modifications were confirmed by MALDI-TOF MS. Mutants were evaluated for Toll-like receptor 4 (TLR4) activation, virulence attenuation, and their ability to induce immune responses and protection in an acute pneumonia model. Results: All engineered strains displayed modified lipid A structures. Mutations in htrB1 and htrB2 reduced TLR4 activation and significantly attenuated virulence following intraperitoneal challenge in mice. Inactivation of pagL resulted in minimal attenuation, whereas pagP inactivation led to marked attenuation without altering TLR4 activation. In the acute pneumonia model, all mutants elicited robust systemic and mucosal immune responses, and conferred strong protection, despite transient weight loss following intranasal administration. Discussion: Targeted lipid A modification represents an effective strategy to reduce in vitro reactogenicity while preserving immunogenicity in live-attenuated P. aeruginosa vaccine candidates. Although further optimization may minimize residual in vivo effects, these findings support the potential of engineered strains as vaccine candidates for preventing respiratory infections caused by P. aeruginosa.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association of lifestyle factors and inflammation with sarcopenic obesity, data from the PREDIMED-Plus trial

  • Abete, Itziar|||0000-0002-6475-5387
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Galmes-Panades, Aina M.|||0000-0001-6977-9874
  • Ibero-Baraibar, Idoia
  • Babio, Nancy|||0000-0003-3527-5277
  • Estruch, Ramón|||0000-0003-1260-4445
  • Vidal, Josep|||0000-0002-4564-4518
  • Toledo, Estefania|||0000-0002-6263-4434
  • Razquín, Cristina|||0000-0003-3480-2645
  • Bartolomé, Rafael
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Fiol-Sala, Miquel
  • Casas, Rosa|||0000-0002-0211-9166
  • Vera, Josep
  • Buil-Cosiales, Pilar|||0000-0002-8586-577X
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corbella, Emili|||0000-0001-8818-1907
  • Portillo, Maria Puy
  • de Paz, José Antonio|||0000-0002-4389-1777
  • Martín, Vicente|||0000-0003-0552-2804
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Rosique-Esteban, Nuria
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Romaguera, Dora|||0000-0002-5762-8558
  • Martínez, J. Alfredo|||0000-0001-5218-6941
Background: Sarcopenia is a progressive age-related skeletal muscle disorder associated with increased likelihood of adverse outcomes. Muscle wasting is often accompanied by an increase in body fat, leading to 'sarcopenic obesity'. The aim of the present study was to analyse the association of lifestyle variables such as diet, dietary components, physical activity (PA), body composition, and inflammatory markers, with the risk of sarcopenic obesity. Methods: A cross-sectional analysis based on baseline data from the PREDIMED-Plus study was performed. A total of 1535 participants (48% women) with overweight/obesity (body mass index: 32.5 ± 3.3 kg/m; age: 65.2 ± 4.9 years old) and metabolic syndrome were categorized according to sex-specific tertiles (T) of the sarcopenic index (SI) as assessed by dual-energy X-ray absorptiometry scanning. Anthropometrical measurements, biochemical markers, dietary intake, and PA information were collected. Linear regression analyses were carried out to evaluate the association between variables. Results: Subjects in the first SI tertile were older, less physically active, showed higher frequency of abdominal obesity and diabetes, and consumed higher saturated fat and less vitamin C than subjects from the other two tertiles (all P < 0.05). Multiple adjusted linear regression models evidenced significant positive associations across tertiles of SI with adherence to the Mediterranean dietary score (P-trend < 0.05), PA (P-trend < 0.0001), and the 30 s chair stand test (P-trend < 0.0001), whereas significant negative associations were found with an inadequate vitamin C consumption (P-trend < 0.05), visceral fat and leucocyte count (all P-trend < 0.0001), and some white cell subtypes (neutrophils and monocytes), neutrophil-to-lymphocyte ratio, and platelet count (all P-trend < 0.05). When models were additionally adjusted by potential mediators (inflammatory markers, diabetes, and waist circumference), no relevant changes were observed, only dietary variables lost significance. Conclusions: Diet and PA are important regulatory mediators of systemic inflammation, which is directly involved in the sarcopenic process. A healthy dietary pattern combined with exercise is a promising strategy to limit age-related sarcopenia.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Isotemporal substitution of inactive time with physical activity and time in bed, cross-sectional associations with cardiometabolic health in the PREDIMED-Plus study

  • Galmes-Panades, Aina M.|||0000-0001-6977-9874
  • Varela-Mato, Veronica
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Schröder, Helmut|||0000-0003-2231-5081
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Micó Pérez, Rafael Manuel|||0000-0002-2575-1236
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Garcia-Arellano, Ana
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Fiol, Francisca
  • Mira-Castejón, Luis Alfredo
  • Moreno Rodríguez, Anai
  • Benavente-Marín, Juan Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Tomaino, Laura
  • Casas, Rosa|||0000-0002-0211-9166
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Galera, Ana
  • Mascaró, Catalina M.
  • Razquín, Cristina|||0000-0003-3480-2645
  • Papandreou, Christopher|||0000-0002-6803-507X
  • Portoles, Olga
  • Pérez-Vega, Karla Alejandra|||0000-0002-7524-2034
  • Fiol-Sala, Miquel
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Vaquero-Luna, Jessica
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m 2) from the PREDIMED-Plus study (). All participants had ≥3 components of the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30 min per day of inactive time to 30 min per day of time in bed was associated with lower BMI, waist circumference and glycated hemoglobin (HbA1c) (all p -values < 0.05). Reallocating 30 min per day of inactive time with 30 min per day of LPA or MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides, and higher body muscle mass and HDL cholesterol (all p-values < 0.05). Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile, Prospective Analysis within the PREDIMED-Plus Trial

  • Tresserra-Rimbau, Anna|||0000-0002-7022-9041
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Babio, Nancy|||0000-0003-3527-5277
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • López-Miranda, José|||0000-0002-8844-0718
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martín, Vicente|||0000-0003-0552-2804
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Fernández de la Puente, María
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Bullón-Vela, Vanessa|||0000-0003-3639-821X
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Gómez-Gracia, Enrique
  • Cases-Pérez, Eugenio
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casañas-Quintana, Tamara
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Santos-Lozano, José Manuel
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Barragán, Rocío|||0000-0001-8072-3791
  • López Grau, Mercè
  • Razquín, Cristina|||0000-0003-3480-2645
  • Goicolea-Güemez, Leire
  • Toledo, Estefania|||0000-0002-6263-4434
  • Vergaz, Manel Vila
  • Lamuela-Raventós, Rosa M.|||0000-0002-1287-4560
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Previous studies suggested that dietary polyphenols could reduce the incidence and complications of type-2 diabetes (T2D); although the evidence is still limited and inconsistent. This work analyzes whether changing to a diet with a higher polyphenolic content is associated with an improved glucose profile. At baseline, and at 1 year of follow-up visits, 5921 participants (mean age 65.0 ± 4.9, 48.2% women) who had overweight/obesity and metabolic syndrome filled out a validated 143-item semi-quantitative food frequency questionnaire (FFQ), from which polyphenol intakes were calculated. Energy-adjusted total polyphenols and subclasses were categorized in tertiles of changes. Linear mixed-effect models with random intercepts (the recruitment centers) were used to assess associations between changes in polyphenol subclasses intake and 1-year plasma glucose or glycosylated hemoglobin (HbA1c) levels. Increments in total polyphenol intake and some classes were inversely associated with better glucose levels and HbA1c after one year of follow-up. These associations were modified when the analyses were run considering diabetes status separately. To our knowledge, this is the first study to assess the relationship between changes in the intake of all polyphenolic groups and T2D-related parameters in a senior population with T2D or at high-risk of developing T2D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inflammatory potential of diet and bone mineral density in a senior Mediterranean population, a cross-sectional analysis of PREDIMED-Plus study

  • García-Gavilán, Jesús F.
  • Paz-Graniel, Indira
  • Babio, Nancy|||0000-0003-3527-5277
  • Romaguera, Dora|||0000-0002-5762-8558
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Martín, Vicente|||0000-0003-0552-2804
  • Martínez, María Ángeles
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • de Paz, José Antonio|||0000-0002-4389-1777
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Bulló, Mònica|||0000-0002-0218-7046
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Inflammation could play a key role in tissue damage and bone metabolism. The modified dietary inflammatory score (M-DIS) is a validated tool to estimate the inflammatory potential of the diet. In the present study, we evaluate the associations between the M-DIS and bone mineral density (BMD) in a senior Mediterranean population with overweight/obesity and metabolic syndrome. Baseline cross-sectional association between the M-DIS and bone mineral density was assessed in 1134 participants of the multicenter PREDIMED-Plus trial (aged 55-75 with overweight/obesity and metabolic syndrome). BMD was measured using Dual-energy X-ray Absorptiometry scans and participants answered a food frequency questionnaire to determine the M-DIS. BMD was categorized as low BMD when T score was equal or lower than -1 and normal BMD in another case. Associations between BMD and M-DIS were evaluated by using linear and logistic regressions adjusted by other co-variates. Participants in the top tertile of the M-DIS had a lower BMD at total femur [β (95% CI) - 0.02 (- 0.04, - 0.01)], trochanter areas [β (95% CI) - 0.03 (- 0.05, - 0.01)] and lumbar spine area [β (95% CI) - 0.03 (- 0.07, 0.01)] (but in the last case, measures were less precise and hence not statistically significant) compared to those in the lower M-DIS tertile. Multiple logistic regression analyses showed that the odds of the total femur and femoral trochanter osteopenia/osteoporosis were higher in participants in the top tertile compared to those in the lowest tertile of M-DIS [OR (95% CI) 1.71 (1.12, 2.64), P for trend 0.015; 2.02 (1.29, 3.21), P for trend 0.002, respectively]. A high pro-inflammatory diet, measured by the M-DIS, is associated with lower BMD in a senior Mediterranean population with metabolic syndrome. The online version contains supplementary material available at 10.1007/s00394-021-02751-5.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Fiol-Sala, Miquel
  • Colom, Antoni|||0000-0001-5041-0778
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Soria-Florido, María Trinidad|||0000-0002-5625-9033
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Pascual, María
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez Pérez, Ana María|||0000-0002-2874-5894
  • Santos-Lozano, José Manuel
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Martínez, María Ángeles
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Bayó, Joan
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Carres, Lourdes
  • Romaguera, Dora|||0000-0002-5762-8558
Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p -values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

  • Testa, Giulia|||0000-0003-4200-8062
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Mora-Maltas, Bernat|||0000-0002-4142-3208
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Granero, Roser|||0000-0001-6308-3198
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Babio, Nancy|||0000-0003-3527-5277
  • Fernández-Carrión, Rebeca
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Ni, Jiaqi
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA. In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Carbon dioxide (CO) emissions and adherence to Mediterranean diet in an adult population, the Mediterranean diet index as a pollution level index

  • García, Silvia
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Mateos, David
  • Pastor, Rosario
  • Álvarez, Laura
  • Rubín, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Guillem-Saiz, Patricia
  • Nishi, Stephanie
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Signes-Pastor, Antonio José
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Vázquez, Zenaida
  • Sorlí, José V.|||0000-0002-0130-2006
  • Pascual, Maria
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Babio, Nancy|||0000-0003-3527-5277
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
Research related to sustainable diets is is highly relevant to provide better understanding of the impact of dietary intake on the health and the environment. To assess the association between the adherence to an energy-restricted Mediterranean diet and the amount of CO emitted in an older adult population. Using a cross-sectional design, the association between the adherence to an energy-reduced Mediterranean Diet (erMedDiet) score and dietary CO emissions in 6646 participants was assessed. Food intake and adherence to the erMedDiet was assessed using validated food frequency questionnaire and 17-item Mediterranean questionnaire. Sociodemographic characteristics were documented. Environmental impact was calculated through greenhouse gas emissions estimations, specifically CO emissions of each participant diet per day, using a European database. Participants were distributed in quartiles according to their estimated CO emissions expressed in kg/day: Q1 (≤2.01 kg CO), Q2 (2.02-2.34 kg CO), Q3 (2.35-2.79 kg CO) and Q4 (≥2.80 kg CO). More men than women induced higher dietary levels of CO emissions. Participants reporting higher consumption of vegetables, fruits, legumes, nuts, whole cereals, preferring white meat, and having less consumption of red meat were mostly emitting less kg of CO through diet. Participants with higher adherence to the Mediterranean Diet showed lower odds for dietary CO emissions: Q2 (OR 0.87; 95%CI: 0.76-1.00), Q3 (OR 0.69; 95%CI: 0.69-0.79) and Q4 (OR 0.48; 95%CI: 0.42-0.55) vs Q1 (reference). The Mediterranean diet can be environmentally protective since the higher the adherence to the Mediterranean diet, the lower total dietary CO emissions. Mediterranean Diet index may be used as a pollution level index.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial

  • Díez-Ricote, Laura
  • San-Cristobal, Rodrigo
  • Concejo, M José
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J Alfredo
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Ros, Emilio|||0000-0002-2573-1294
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • García-Gavilán, Jesús F.
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • Martínez-Urbistondo, Diego
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • García Rodríguez, Antonio
  • Gómez-Bellvert, Nuria
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Bernal-López, Rosa M.
  • Santos-Lozano, José M.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Sorlí, José V.|||0000-0002-0130-2006
  • Murphy, Michelle
  • Gasulla, Griselda|||0000-0003-4018-5786
  • Micó, Víctor
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Goñi Ochandorena, Estibaliz
  • Babio, Nancy|||0000-0003-3527-5277
  • Herraiz, Xavier
  • Ordovás, José M.
  • Daimiel, Lidia|||0000-0001-9898-6629
Choline and betaine intakes have been related to cardiovascular health. We aimed to explore the relation between 1-y changes in dietary intake of choline or betaine and 1-y changes in cardiometabolic and renal function traits within the frame of the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial. We used baseline and 1-y follow-up data from 5613 participants (48.2% female and 51.8% male; mean ± SD age: 65.01 ± 4.91 y) to assess cardiometabolic traits, and 3367 participants to assess renal function, of the Spanish PREDIMED-Plus trial. Participants met ≥3 criteria of metabolic syndrome and had overweight or obesity [BMI (in kg/m 2) ≥27 and ≤40]. These criteria were similar to those of the PREDIMED parent study. Dietary intakes of choline and betaine were estimated from the FFQ. The greatest 1-y increase in dietary choline or betaine intake (quartile 4) was associated with improved serum glucose concentrations (-3.39 and -2.72 mg/dL for choline and betaine, respectively) and HbA1c levels (-0.10% for quartile 4 of either choline or betaine intake increase). Other significant changes associated with the greatest increase in choline or betaine intake were reduced body weight (-2.93 and -2.78 kg, respectively), BMI (-1.05 and -0.99, respectively), waist circumference (-3.37 and -3.26 cm, respectively), total cholesterol (-4.74 and -4.52 mg/dL, respectively), and LDL cholesterol (-4.30 and -4.16 mg/dL, respectively). Urine creatinine was reduced in quartile 4 of 1-y increase in choline or betaine intake (-5.42 and -5.74 mg/dL, respectively). Increases in dietary choline or betaine intakes were longitudinally related to improvements in cardiometabolic parameters. Markers of renal function were also slightly improved, and they require further investigation. This trial was registered at as ISRCTN89898870.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat-Mesquida, Margalida
  • Álvarez-Álvarez, Laura
  • Rubín-García, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Guillem-Saiz, Patricia
  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Tercero-Maciá, Cristina
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío|||0000-0001-8072-3791
  • Khoury, Nadine
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Bouzas, Cristina|||0000-0002-1407-8461
Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. To assess the association between MetS severity and amount of carbon dioxide (CO) emitted in an adult population. Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Higher glycaemia levels were found in people with higher CO emissions. The risk of having high severe MetS was related to high CO emissions. Low CO emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. ISRCTN, . Registered 05 September 2013.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome, The PREDIMED Plus Cohort

  • Martínez-Urbistondo, Diego
  • San Cristóbal, RodrigoSan
  • Villares, Paula
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Del Val García, José Luis|||0000-0002-0391-9368
  • Ordovás, José M.
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Marcos, Alba
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Bullón Vela, María Vanessa
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Masagué, Marta
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodríguez, Anai
  • Candela-García, Inma
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Juárez, Oscar Lecea
  • Martín, Paco
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Orea, María del Carmen Sayón
  • Megías, Isabel
  • Baltasar, Enric
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Daimiel, Lidia|||0000-0001-9898-6629
To evaluate the effect of Non-alcoholic fatty liver disease (NAFLD) status in the impact of lifestyle over Health-related quality of life (HRQoL) in patients with metabolic syndrome (MetS). Baseline and 1 year follow up data from the PREDIMED-plus cohort (men and women, 55-75 years old with overweight/obesity and MetS) were studied. Adherence to an energy-restricted Mediterranean Diet (er-MeDiet) and Physical Activity (PA) were assessed with a validated screeners. Hepatic steatosis index (HSI) was implemented to evaluate NAFLD while the SF-36 questionnaire provided HRQoL evaluation. Statistical analyses were performed to evaluate the influence of baseline NAFLD on HRQoL as affected by lifestyle during 1 year of follow up. Data from 5205 patients with mean age of 65 years and a 48% of female participants. Adjusted linear multivariate mixed regression models showed that patients with lower probability of NAFLD (HSI < 36 points) were more responsive to er-MeDiet (β 0.64 vs β 0.05 per er-MeDiet adherence point, p< 0.01) and PA (β 0.05 vs β 0.01 per MET-h/week, p = 0.001) than those with high probability for NAFLD in terms Physical SF-36 summary in the 1 year follow up. 10 points of er-MeDiet adherence and 50 MET-h/week were thresholds for a beneficial effect of lifestyle on HRQoL physical domain in patients with lower probability of NAFLD. The evaluation of NAFLD by the HSI index in patients with MetS might identify subjects with different prospective sensitivity to lifestyle changes in terms of physical HRQoL ().
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between ultra-processed food consumption and gut microbiota in senior subjects with overweight/obesity and metabolic syndrome

  • Atzeni, Alessandro
  • Martínez, María Ágeles
  • Babio, Nancy|||0000-0003-3527-5277
  • Konstanti, Prokopis
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Vioque, Jesús|||0000-0002-2284-148X
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Vidal, Josep|||0000-0002-4564-4518
  • Moreno-Indias, Isabel
  • Pertusa-Martinez, Salvador
  • Alvarez-Sala, Andrea
  • Castañer, Olga|||0000-0003-3169-997X
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Damas-Fuentes, Miguel
  • Belzer, Clara
  • Martínez-Gonzalez, Miguel Á.
  • Hu, Frank B..
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
The production and consumption of ultra-processed foods (UPF) has increased considerably during the last years worldwide. Collective evidence shows the association between UPF consumption and adverse health outcomes, including inflammatory gastro-intestinal disorders and obesity. The gut microbiota has been suggested as potential mediator of the effects of UPF consumption on metabolism and health. However, few studies have been conducted in order to elucidate these aspects. Therefore, the aim of the present study was to assess the cross-sectional associations between UPF consumption and gut microbiota in a population of senior subjects (n = 645) within the frame of the PREDIMED-Plus trial. Eligible participants were men and women (aged 55-75 years), without documented history of cardiovascular disease at enrollment, with overweight/obesity (body mass index ≤ 27 and <40 kg/m 2) and metabolic syndrome. Using the information of food frequency questionnaires, the consumption of UPF, expressed as a percentage of total dietary energy intake in kcal/day, was calculated considering those food items classified in group 4 of NOVA system. Population was categorized according to tertiles of UPF consumption. Taxonomic fecal microbiota information, along with blood biochemical parameters, anthropometric measurements and clinical data were obtained. Bioinformatics analysis was performed to study the association between fecal microbiota composition and UPF consumption. We observed that subjects allocated in the highest tertile of UPF consumption (21.4 ± 5.0 % kcal/day) presented lower adherence to MedDiet (p < 0.001) and higher total energy intake (p < 0.001). The taxonomic analysis of the fecal microbiota revealed a significant (Benjamini-Hochberg adjusted p < 0.2) positive association between specific taxa and tertiles (T) of UPF consumption: Alloprevotella (p = 0.041 vs. T2; p = 0.065 vs. T3), Negativibacillus (p = 0.096 vs. T3), Prevotella (p = 0.116 vs. T3), and Sutterella (p = 0.116 vs. T2). UPF consumption was positively associated with lower adherence to MedDiet and higher total energy intake in senior subjects with overweight obesity and metabolic syndrome. In addition, positive association with specific fecal microbiota taxa related to inflammatory gastro-intestinal diseases and low consumption of fruits and vegetables, was observed.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Megías, Isabel
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Amengual-Galbarte, Angela
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • García-Arellano, Ana
  • Barragán, Rocío|||0000-0001-8072-3791
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Peña-Orihuela, Patricia J.
  • Asencio-Aznar, Alberto
  • Gómez-Gracia, Enrique
  • Martinez-Urbistondo, Diego
  • Morey, Marga
  • Casas, Rosa|||0000-0002-0211-9166
  • Garrido-Garrido, Eva María
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Damas-Fuentes, Miguel
  • Goñi, Estibaliz
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Castañer, Olga|||0000-0003-3169-997X
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Gisbert-Sellés, Cristina
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Schröder, Helmut|||0000-0003-2231-5081
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Diets high in acid load may contribute to kidney function impairment. This study aimed to investigate the association between dietary acid load and 1-year changes in glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (UACR). Older adults with overweight/obesity and metabolic syndrome (mean age 65 ± 5 years, 48% women) from the PREDIMED-Plus study who had available data on eGFR (n = 5,874) or UACR (n = 3,639) at baseline and after 1 year of follow-up were included in this prospective analysis. Dietary acid load was estimated as potential renal acid load (PRAL) and net endogenous acid production (NEAP) at baseline from a food frequency questionnaire. Linear and logistic regression models were fitted to evaluate the associations between baseline tertiles of dietary acid load and kidney function outcomes. One year-changes in eGFR and UACR were set as the primary outcomes. We secondarily assessed ≥ 10% eGFR decline or ≥10% UACR increase. After multiple adjustments, individuals in the highest tertile of PRAL or NEAP showed higher one-year changes in eGFR (PRAL, β: -0.64 ml/min/1.73 m 2 ; 95% CI: -1.21 to -0.08 and NEAP, β: -0.56 ml/min/1.73 m 2 ; 95% CI: -1.13 to 0.01) compared to those in the lowest category. No associations with changes in UACR were found. Participants with higher levels of PRAL and NEAP had significantly higher odds of developing ≥10% eGFR decline (PRAL, OR: 1.28; 95% CI: 1.07-1.54 and NEAP, OR: 1.24; 95% CI: 1.03-1.50) and ≥10 % UACR increase (PRAL, OR: 1.23; 95% CI: 1.04-1.46) compared to individuals with lower dietary acid load. Higher PRAL and NEAP were associated with worse kidney function after 1 year of follow-up as measured by eGFR and UACR markers in an older Spanish population with overweight/obesity and metabolic syndrome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

  • Micó, Victor
  • San-Cristobal, Rodrigo
  • Martín, Roberto
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • García-Arellano, Ana
  • Pertusa-Martinez, Salvador
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Muñoz Bravo, Carlos
  • Schröder, Helmut|||0000-0003-2231-5081
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Gonzalez, Jose I.
  • Martinez-Urbistondo, Diego
  • Toledo, Estefania|||0000-0002-6263-4434
  • Bullón, Vanessa
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Portillo, María Puy
  • Macías-González, Manuel
  • Perez-Diaz-del-Campo, Nuria
  • García-Gavilán, Jesús
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martínez, J Alfredo
Metabolic syndrome (MetS) is one of the most important medical problems around the world. Identification of patient's singular characteristic could help to reduce the clinical impact and facilitate individualized management. This study aimed to categorize MetS patients using phenotypical and clinical variables habitually collected during health check-ups of individuals considered to have high cardiovascular risk. The selected markers to categorize MetS participants included anthropometric variables as well as clinical data, biochemical parameters and prescribed pharmacological treatment. An exploratory factor analysis was carried out with a subsequent hierarchical cluster analysis using the z-scores from factor analysis. The first step identified three different factors. The first was determined by hypercholesterolemia and associated treatments, the second factor exhibited glycemic disorders and accompanying treatments and the third factor was characterized by hepatic enzymes. Subsequently four clusters of patients were identified, where cluster 1 was characterized by glucose disorders and treatments, cluster 2 presented mild MetS, cluster 3 presented exacerbated levels of hepatic enzymes and cluster 4 highlighted cholesterol and its associated treatments Interestingly, the liver status related cluster was characterized by higher protein consumption and cluster 4 with low polyunsaturated fatty acid intake. This research emphasized the potential clinical relevance of hepatic impairments in addition to MetS traditional characterization for precision and personalized management of MetS patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Population

  • Khoury, Nadine
  • Gómez Donoso, Clara|||0000-0003-4753-3560
  • Martínez, María Ángeles
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • León-Acuña, Ana
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Massó, Paloma|||0000-0002-3519-9254
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Barragán, Rocío|||0000-0001-8072-3791
  • Castañer, Olga|||0000-0003-3169-997X
  • Torres-Peña, Jose David
  • Notario Barandiaran, Leyre|||0000-0003-0517-6307
  • Muñoz-Bravo, Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Prohens, Lara
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Pascual, Maria
  • Sorlí, José V.|||0000-0002-0130-2006
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Peña-Orihuela, Patricia J.
  • Signes-Pastor, Antonio J.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Schröeder, Helmut
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Background: Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm-NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic blood pressure. Materials and Methods: Dietary intake was assessed at baseline and after 1 year of follow-up using a 143-item validated semi-quantitative food-frequency questionnaire. Dietary indices based on FSAm-NPS applied at an individual level were computed to characterize the diet quality of 5,921 participants aged 55-75 years with overweight/obesity and metabolic syndrome from the PREDIMED-plus cohort. Associations between the FSAm-NPS DI and CVD risk factors were assessed using linear regression models. Results: Compared to participants with a higher nutritional quality of diet (measured by a lower FSAm-NPS DI at baseline or a decrease in FSAm-NPS DI after 1 year), those participants with a lower nutritional quality of diet (higher FSAm-NPS DI or an increase in score) showed a significant increase in the levels of plasma glucose, triglycerides, diastolic blood pressure, BMI, and waist circumference (β coefficient [95% confidence interval]; P for trend) (1.67 [0.43, 2.90]; <0.001; 6.27 [2.46, 10.09]; <0.001; 0.56 [0.08, 1.05]; 0.001; 0.51 [0.41, 0.60]; <0.001; 1.19 [0.89, 1.50]; <0.001, respectively). No significant associations in relation to changes in HDL and LDL-cholesterol nor with systolic blood pressure were shown. Conclusion: This prospective cohort study suggests that the consumption of food items with a higher FSAm-NPS DI is associated with increased levels of several major risk factors for CVD including adiposity, fasting plasma glucose, triglycerides, and diastolic blood pressure. However, results must be cautiously interpreted because no significant prospective associations were identified for critical CVD risk factors, such as HDL and LDL-cholesterol, and systolic blood pressure.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Ruiz García, Verónica|||0000-0002-7405-2319
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Rubín García, María|||0000-0003-0916-4215
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Toledo, Estefania|||0000-0002-6263-4434
  • Sorlí, José V.|||0000-0002-0130-2006
  • Roca, C.
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodriguez, Anai
  • Crespo-Oliva, Edelys
  • Candela-García, Inmaculada
  • Morey, Marga
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Diez-Espino, Javier
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Comas, Mercè
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Sorto-Sanchez, Carolina
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
To assess the association between three different a priori dietary patterns adherence (17-item energy reduced-Mediterranean Diet (MedDiet), Trichopoulou-MedDiet and Dietary Approach to Stop Hypertension (DASH)), as well as the Protein Diet Score and kidney function decline after one year of follow-up in elderly individuals with overweight/obesity and metabolic syndrome (MetS). We prospectively analyzed 5675 participants (55-75 years) from the PREDIMED-Plus study. At baseline and at one year, we evaluated the creatinine-based estimated glomerular filtration rate (eGFR) and food-frequency questionnaires-derived dietary scores. Associations between four categories (decrease/maintenance and tertiles of increase) of each dietary pattern and changes in eGFR (ml/min/1.73m) or ≥ 10% eGFR decline were assessed by fitting multivariable linear or logistic regression models, as appropriate. Participants in the highest tertile of increase in 17-item erMedDiet Score showed higher upward changes in eGFR (β: 1.87 ml/min/1.73m; 95% CI: 1.00-2.73) and had lower odds of ≥ 10% eGFR decline (OR: 0.62; 95% CI: 0.47-0.82) compared to individuals in the decrease/maintenance category, while Trichopoulou-MedDiet and DASH Scores were not associated with any renal outcomes. Those in the highest tertile of increase in Protein Diet Score had greater downward changes in eGFR (β: - 0.87 ml/min/1.73m; 95% CI: - 1.73 to - 0.01) and 32% higher odds of eGFR decline (OR: 1.32; 95% CI: 1.00-1.75). Among elderly individuals with overweight/obesity and MetS, only higher upward change in the 17-item erMedDiet score adherence was associated with better kidney function after one year. However, increasing Protein Diet Score appeared to have an adverse impact on kidney health. Trial Registration Number: ISRCTN89898870 (Data of registration: 2014).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Deprivation Index and Lifestyle, Baseline Cross-Sectional Analysis of the PREDIMED-Plus Catalonia Study

  • Basora, Josep|||0000-0003-0278-1149
  • Villalobos, Felipe|||0000-0002-6907-8354
  • Pallejà-Millán, Meritxell|||0000-0003-1985-8894
  • Babio, Nancy|||0000-0003-3527-5277
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Pintó, Xavier|||0000-0002-2216-2444
  • Sacanella, Emilio|||0000-0001-8018-1523
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
This baseline cross-sectional analysis from data acquired in a sub-sample of the PREDIMED-Plus study participants aimed to evaluate the relation between the Composite Socioeconomic Index (CSI) and lifestyle (diet and physical activity). This study involved 1512 participants (759 (52.2%) women) between 55 and 80 years with overweight/obesity and metabolic syndrome assigned to 137 primary healthcare centers in Catalonia, Spain. CSI and lifestyle (diet and physical activity) were assessed. Multiple linear regression or multinomial regression were applied to the data. Cluster analysis was performed to identify dietary patterns. The multiple linear regression model showed that a high deprivation index was related to a higher consumption of refined cereals (11.98 g/d, p -value = 0.001) and potatoes (6.68 g/d, p -value = 0.001), and to a lower consumption of fruits (-17.52 g/d, p -value = 0.036), and coffee and tea (-8.03 g/d, p -value = 0.013). Two a posteriori dietary patterns were identified by cluster analysis and labeled as "healthy" and "unhealthy". In addition, the multinomial regression model showed that a high deprivation index was related to an unhealthy dietary pattern and low physical activity (OR 1.42 [95% CI 1.06-1.89]; p -value < 0.05). In conclusion, a high deprivation index was related to an unhealthy lifestyle (diet and physical activity) in PREDIMED-Plus study participants.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Granero, Roser|||0000-0001-6308-3198
  • Razquin, C.
  • Corella, D.
  • Gómez-Martínez, C.
  • Castañer-Niño, O.
  • Martínez, J. A.
  • Alonso-Gómez, Á. M.
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, D.
  • López-Miranda, J.
  • Estruch, R.
  • Tinahones, F. J.
  • Lapetra, J.
  • Serra-Majem, J. L.
  • Cano-Ibáñez, N.
  • Tur, J. A.
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, J. J.
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, E.
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Dalsgaard, S.
  • Garcia-Arellano, A.
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Lassale, C.
  • García-de-la-Hera, M.
  • Gómez-García, E.
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Konieczna, J.
  • Martín Peláez, Sandra|||0000-0002-2193-3913
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Basterra-Gortari, F. J.
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Portoles, O.
  • Muñoz, Miguel-Angel|||0000-0002-4083-3248
  • Arenas-Larriva, A. P.
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Eguaras, Sonia
  • Shyam, S.
  • Fitó, M.
  • Baños, Rosa|||0000-0003-0626-7665
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
To examine the cross-sectional association between baseline depressive symptoms and the presence of type 2 diabetes (T2D), and its association with glycated hemoglobin (HbA1c) and other metabolic variables, and the prospective association of depressive symptoms and HbA1c after 1 year of follow-up. n = 6224 Mediterranean older adults with overweight/obesity and metabolic syndrome (48% females, mean age 64.9 ± 4.9 years) were evaluated in the framework of the PREDIMED-Plus study cohort. Depressive symptoms were assessed using the Beck Depression Inventory-II and HbA1c was used to measure metabolic control. The presence of T2D increased the likelihood of higher levels of depressive symptoms (χ 2 = 15.84, p = 0.001). Polynomial contrast revealed a positive linear relationship (χ 2 = 13.49, p = 0.001), the higher the depressive symptoms levels, the higher the prevalence of T2D. Longitudinal analyses showed that the higher baseline depressive symptoms levels, the higher the likelihood of being within the HbA1c ≥ 7% at 1-year level (Wald-χ 2 = 24.06, df = 3, p < .001, for the full adjusted model). Additionally, depressive levels at baseline and duration of T2D predicted higher HbA1c and body mass index, and lower physical activity and adherence to Mediterranean Diet at 1 year of follow-up. This study supports an association between T2D and the severity of depressive symptoms, suggesting a worse metabolic control from mild severity levels in the short-medium term, influenced by lifestyle habits related to diabetes care. Screening for depressive symptoms and a multidisciplinary integrative therapeutic approach should be ensured in patients with T2D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Psychological and metabolic risk factors in older adults with a previous history of eating disorder, A cross-sectional study from the Predimed-Plus study

  • Vintró Alcaraz, Cristina|||0000-0001-9453-8810
  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Lozano Madrid, María|||0000-0003-3833-317X
  • Granero, Roser|||0000-0001-6308-3198
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Sanchez Villegas, Almudena|||0000-0001-7733-9238
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Cárdenas, Jersy J.|||0000-0002-2485-484X
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Razquín, Cristina|||0000-0003-3480-2645
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • González, José I.
  • Forcano, Laura|||0000-0002-8478-1451
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Bello-Mora, Maria C.
  • Valenzuela-Guerrero, Silvia|||0000-0001-7467-8672
  • Garcia de La Hera, Manoli|||0000-0001-5742-2704
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez-Pérez, Ana M
  • Garcia Arellano, Ana|||0000-0003-1491-9627
  • Bulló, Mònica|||0000-0002-0218-7046
  • Sorlí, José V.|||0000-0002-0130-2006
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Goals: To explore affective and cognitive status, later in life, in individuals with and without previous history of eating disorder (ED), and also its association with higher risk for metabolic syndrome (MetS) symptomatology. Methods: A cross-sectional analysis of 6756 adults, aged 55-75 years with overweight/obesity and MetS participating in the Predimed-Plus study was conducted. Participants completed self-reported questionnaires to examine lifetime history of ED, according to DSM-5 criteria, and other psychopathological and neurocognitive factors. Anthropometric and metabolic measurements were also collected. Results: Of the whole sample, 24 individuals (0.35%) reported a previous history of ED. In this subsample, there were more women and singles compared to their counterparts, but they also presented higher levels of depressive symptoms and higher cognitive impairment, but also higher body mass index (BMI) and severe obesity, than those without lifetime ED. Conclusions: This is one of the first studies to analyse the cognitive and metabolic impact of a previous history of ED. The results showed that previous ED was associated with greater affective and cognitive impairment, but also with higher BMI, later in life. No other MetS risk factors were found, after controlling for relevant variables.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Consensus document on frailty: conceptualization, detection, multidisciplinary management and future roadmap

  • Álvarez Bustos, Alejandro
  • Andrés-Lacueva, Cristina
  • Ara, Ignacio
  • Arévalo, María Ángeles
  • Bolaños, Juan P.
  • Coto-Montes, Ana
  • Enríquez, José Antonio
  • Escames, Germaine
  • García García, Francisco José
  • Gómez Cabrera, Mari Carmen
  • Grau-Rivera, Oriol
  • Izquierdo Redín, Mikel
  • Martínez Velilla, Nicolás
  • Matheu, Ander
  • Menéndez Colino, Rocío
  • Muñoz Torres, Manuel
  • Nogués, Xavier
  • Oliva Moreno, Juan
  • Orts-Cortés, María Isabel
  • Párraga Martínez, Ignacio
  • Priego, Feliciano
  • Rabassa-Bonet, Montserrat
  • Rol, María Ángeles
  • Serra-Rexach, José Antonio
  • Tarazona-Santabalbina, Francisco José
  • Rodríguez Mañas, Leocadio
  • Abizanda, Pedro
  • CIBERFES Working Group
Background: The lack of a universally accepted definition, a gold-standard assessment tool, and sufficient evidence-based interventions has hindered the integration of frailty into routine clinical practice, particularly outside geriatric medicine. For clinicians, health professionals, policymakers, and aging researchers, a unified framework based on robust evidence has become essential. Objectives: To provide a consensus on relevant aspects of frailty, including definition, attributes, misunderstandings, pathophysiology, phenotypes, assessment, biomarkers, management, stigmas and future challenges, useful for epidemiological, clinical and research application across Europe. Design: Consensus document. Setting: 25 research centers on frailty and healthy aging. Measurements: Relevant aspects on frailty. Results: In this document we present a consensus regarding what frailty is, what frailty is not, what is aging, which are the most common misunderstandings related to frailty, which is the pathophysiology and which are the biomarkers of frailty, how should frailty be assessed and who should assess frailty, how should frailty be managed, the presence or absence of frailty subphenotypes or subtypes, how is the stigma of been considered frail, which are the gender considerations, and which are the current challenges and future directions. We support that frailty is the expression of an age-associated clinical phenotypic syndrome driven by the biology of aging, life-course environmental exposures, and disease burden. Its physiological basis lies in a heterogeneous decline of functional reserve across organ systems, accompanied by impaired homeostasis and reduced capacity to respond to stressors, ultimately predisposing to adverse health outcomes, mainly disability. Conclusions: We present a consensus document on frailty, useful for epidemiological, clinical and research application across Europe., The present study received funding from the projects CB16/10/00408, CB16/10/00269, CB16/10/00477, CB16/10/00383, CB16/10/00282, CB16/10/00289, CB16/10/00238, CB16/10/00456, CB16/10/00435, CB16/10/00417, CB16/10/00315, CB16/10/00496, CB16/10/00468, CB16/10/00475, CB16/10/00245, CB23/10/00037, CB16/10/00501, CB16/10/00464, CB16/10/00239, CB16/10/00314, Instituto de Salud Carlos III, Madrid, Spain.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

  • Garbayo, Elisa
  • Ruiz-Villalba, Adrián
  • Hernández, Silvia C.
  • Saludas, Laura
  • Abizanda, Gloria
  • Pelacho, Beatriz
  • Roncal Mancho, Carmen
  • Sánchez, B. (Belén)
  • Palacios, Itziar
  • Prósper, Felipe
  • Blanco-Prieto, María J.
Despite tremendous progress in cell-based therapies for heart repair, many challenges still exist. To enhance the therapeutic potential of cell therapy one approach is the combination of cells with biomaterial delivery vehicles. Here, we developed a biomimetic and biodegradable micro-platform based on polymeric microparticles (MPs) capable of maximizing the therapeutic potential of cardiac progenitor cells (CPCs) and explored its efficacy in a rat model of chronic myocardial infarction. The transplantation of CPCs adhered to MPs within the infarcted myocardial microenvironment improved the long-term engraftment of transplanted cells for up to one month. Furthermore, the enhancement of cardiac cellular retention correlated with an increase in functional recovery. In consonance, better tissue remodeling and vasculogenesis were observed in the animals treated with cells attached to MPs, which presented smaller infarct size, thicker right ventricular free wall, fewer deposition of periostin and greater density of vessels than animals treated with CPCs alone. Finally, we were able to show that part of this beneficial effect was mediated by CPC-derived extracellular vesicles (EVs). Taken together, these findings indicate that the biomimetic microcarriers support stem cell survival and increase cardiac function in chronic myocardial infarction through modulation of cardiac remodeling, vasculogenesis and CPCs-EVs mediated therapeutic effects. The biomimetic microcarriers provide a solution for biomaterial-assisted CPC delivery to the heart., This work was supported by the FEDER/Ministry of Science and Innovation-State Research Agency/SAF2017-83734-R and funds from the ISCIII and co-financed by FEDER (PI19/00501), Red TERCEL RETIC RD16/0011/0005 and MINECO (Program RETOS Cardiomesh RTC-2016-4911-1), ERANET II (Nanoreheart AC15/00050), and EU's H2020 Programme for research, technological development and demonstration under grant agreement BRAV¿-874827. Elisa Garbayo is supported by a FSE/Ministry of Science and Innovation-State Research Agency RYC2018-025897-I. Adrian Ruiz-Villalba is supported by the Spanish Ministry of Sciences and Innovations FSE/MINECO-AEI(IJCI-2016-30254), and the Spanish Ministerio de Ciencia, Innovación y Universidades (grant RTI2018-095410-BI00). We thank Filippo Roli and Elena Iglesias for technical support.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Ros, Emilio
  • Basterra Gortari, Francisco Javier
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos Lozano, José Manuel
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Tur, Josep A.
  • Fernández-García, José Manuel
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Fernández-Aranda, Fernando
  • Ruiz Canela, Miguel
  • Mestres Solà, Cristina
  • Portolés, Olga
  • Sala Vila, Aleix
  • García-Ríos, Antonio
  • Compañ-Gabucio, Laura María
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Chaplin, Alice
  • Casas, Rosa
  • Martínez Diz, Silvia
  • Tojal-Sierra, Lucas
  • Gómez Pérez, Ana María
  • Toledo, Estefanía
  • Ríos, Santiago
  • Ortega Azorín, Carolina
  • Torre, Rafael de la
  • Peña-Orihuela, Patricia J.
  • García de la Hera, Manuela
  • Sayón-Orea, Carmen
  • Malcampo, Mireia
  • Salas-Salvadó, Jordi
Background: Tree nuts and peanuts (henceforth, nuts) are nutrient-dense foods rich in neuroprotective components; thus, their consumption could benefit cognitive health. However, evidence to date is limited and inconsistent regarding the potential benefits of nuts for cognitive function. Objective: To prospectively evaluate the association between nut consumption and 2-y changes in cognitive performance in older adults at cognitive decline risk. Methods: A total of 6,630 participants aged 55 to 75 y (mean age 65.04.9 y, 48.4% women) with overweight/obesity and metabolic syndrome completed a validated semi-quantitative food frequency questionnaire and a comprehensive battery of neuropsychological tests at baseline and a 2-y follow-up. Composite cognitive scores were used to assess global, general, attention, and executive function domains. Nut consumption was categorized as <1, 1 to <3, 3 to <7, and 7 servings/wk (1 serving¼30 g). Multivariable-adjusted linear regression models were fitted to assess associations between baseline nut consumption and 2-y cognitive changes. Results: Nut consumption was positively associated with 2-y changes in general cognitive function (P-trend <0.001). Compared with participants consuming <1 serving/wk of nuts, those categorized as consuming 3 to <7 and 7 servings/wk showed more favorable changes in general cognitive performance (β z-score [95% CI] ¼ 0.06 [0.00,0.12] and 0.13 [0.06,0.20], respectively). No significant changes were observed in the multivariableadjusted models for other cognitive domains assessed. Conclusion: Frequent nut consumption was associated with a smaller decline in general cognitive performance over 2 y in older adults at risk of cognitive decline. Randomized clinical trials to verify our findings are warranted., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutricion (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS), which is co-funded by the European Regional Development Fund (6 coordinated FIS projects leaded by JS-S and JoV, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/ 00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/ 01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/ 00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/ 00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/ 00886, PI20/01158); the Especial Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad física Cohorte PREDIMED-Plus grant and the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the European Research Council (Advanced Research Grant 2014–2019; agreement #340918); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/ 017 and PROMETEO/2021/021 grants from the Consellería de Innovacion, Universidades, Ciencia y Sociedad digital de la Generalitat Valenciana; Grant PID2019-108858RB-I00 funded by AEI 10.13039/ 501100011033 and by “ERDF A way of making Europe”; the SEMERGEN grant; the AICO/2021/347 grants from the Generalitat Valenciana. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2); and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). JN is supported by a predoctoral grant from Ministerio de Ciencia, Innovacion y Universidades (FPU 20/ 00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Adherence to the Mediterranean diet and frailty criteria in an old population with metabolic syndrome: a cross-sectional analysis

  • Torrego Ellacuría, Macarena
  • Cuesta Triana, Federico
  • Ortiz Ramos, María
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Vázquez-Lorente, Héctor
  • Fitó, Montserrat
  • Martínez, José Alfredo
  • Tojal-Sierra, Lucas
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos-Lozano, J. M.
  • Serra-Majem, Lluis
  • Bueno-Cavanillas, A.
  • Tur, Josep A.
  • Romero Vigara, Juan Carlos
  • Pintó, Xavier
  • Gaforio, José J.
  • Vidal, Josep
  • Mas-Fontao, Sebastián
  • Daimiel, Lidia
  • Chiva-Blanch, Gema
  • Basterra Gortari, Francisco Javier
  • Gutierrez, Liliana
  • Sorli, Jose V.
  • Minguella Muñoz, Elisa
  • García-Ríos, Antonio
  • Bernabé Casanova, Andrea
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Nafría, Mar
  • Casas, Rosa
  • Garrido-Garrido, Eva M.
  • Goicolea-Güemez, Leire
  • Gómez Pérez, Ana María
  • Ruiz Canela, Miguel
  • Megias, Isabel
  • Valero Barceló, Carmen
  • Montenegro Calvo, Marina
  • Peña-Orihuela, Patricia J.
  • Tercero Marciá, Cristina
  • Razquin, Cristina
  • Babio, Nancy
  • Sala de Vedruna, Adriana
  • Barabash Bustelo, Ana
  • Matía-Martín, Pilar
Objectives: Frailty has emerged as a key indicator of biological aging. This study aimed to assess the relationship between MedDiet adherence and frailty prevalence in the context of metabolic syndrome (MetS). Design: Cross-sectional study. Baseline data from PREDIMED-Plus trial Setting: Primary care health, 23 recruitment sites (2013–2016). Participants: A total of 6874 participants with overweight/obesity and ≥3 MetS components. Measurements: Adherence to the MedDiet: 17-item MedDiet score. Frailty and prefrailty (3 or 1–2 criteria): modified Fried Frailty Index (FFI), considering exhaustion, physical activity and functional capacity. Main independent variable was analysed: as a continuous variable (range: 0–17); in quartiles of adherence using univariate and multivariate logistic regression models adjusted for potential confounders. Results: Prefrailty and frailty prevalence were 49.7% and 2.9%, respectively. Compared to those with the lowest MedDiet adherence (0–6), participants with the highest adherence (11–17) had significantly lower odds of meeting frailty criteria. Fully adjusted models showed ORs of 0.479 (p = 0.097) for frailty, 0.705 (p = 0.001) for prefrailty, and 0.694 (p = 0.001) for frailty or prefrailty in participants with higher/greater MedDiet adherence. Each 1-point increase in the 17-item score was associated with an OR ranging from 0.878 to 0.977 (p < 0.05 for all comparisons, except functional capacity: p = 0.100). When adherence was dichotomized, the adjusted ORs ranged from 0.406 to 0.834 (p < 0.05 for all comparisons). Conclusions: Higher adherence to MedDiet was associated with a lower prevalence of frailty and prefrailty in older adults with overweight/obesity and MetS, reinforcing its potential role in promoting healthy aging despite cardiometabolic comorbidities., This work was supported by official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund(six coordinated FIS projects including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); an NIH grant1R01DK127601, the European Research Council advanced research grant 2014–2019; agreement 340918, and the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant; the Recercaixa grant (2013ACUP00194); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013,PS0358/2016,PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGENgrant; INSA-Ma María de Maeztu Unit of Excellence (grant CEX2021-001234-M funded by MICIN/AEI/FEDER, UE); Juan de la Cierva Research Grant (IJC2019-042420-I/AEI/ 10.13039/501100011033) from Agencia Estatal de Investigación to J.K., and a contract financed by the Government of the Balearic Islands Funds was partially supported by ICREA under the ICREA Academia program; Nutrition Grant from the Sociedad Española de Endocrinología y Nutrición Foundation(FSEEN, 2022) to PMM. HVL was funded by a research grant from the Agència de Gestió d’Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV-01)
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study

  • Martín Peláez, Sandra
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Martínez González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Lassale, Camille
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Fernández-Aranda, Fernando
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín, Vicente
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Nishi, Stephanie K.
  • Sorli, Jose V.
  • Malcampo, Mireia
  • Zulet, María Ángeles
  • Moreno Rodríguez, Anaí
  • Cueto Galán, Raquel
  • Vivancos Aparicio, Diego
  • Colom Fernández, Antoni
  • García-Ríos, Antonio
  • Casas, Rosa
  • Bernal López, M. Rosa
  • Santos Lozano, José Manuel
  • Vázquez, Zenaida
  • Gómez-Martínez, Carlos
  • Ortega Azorín, Carolina
  • Val, José Luis del
  • Abete, Itziar
  • Goikoetxea Bahon, Amaia
  • Pascual, Elena
  • Becerra-Tomás, Nerea
  • Chillarón, Juan J.
  • Sánchez Villegas, María Almudena
Background Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55-75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. Methods and findings Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ¿280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41 ±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240-279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). Conclusions Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response., The PREDIMED-Plus trial was supported by the European Research Council through a grant to MAM (Advanced Research Grant 2013-2018; 340918). The project was also supported by the official funding agency for biomedical research of the Spanish Government (ISCIII) through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (four coordinated FIS projects), who awarded grants to JS and JV (PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732 and PI17/00926). The International Nut&Dried Fruit Council-FESNAD also provided funding through a grant to MAM (201302), and Recercaixa also awarded a grant to JS (2013ACUP00194). The Department of Health, Generalitat de Cataluña by the calls 'Acció instrumental de programes de recerca orientats en lámbit de la recercaila innovació en salut' and 'Pla estrategic de recerca i innovació en salut (PERIS),' also awarded a grant to FF (SLT006/17/00246). This research was also partially funded by: Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); Generalitat Valenciana (PROMETEO/2017/017); SEMERGEN, CIBEROBN, FEDER and ISCIII (CB06/03); EU-H2020 Grants (Eat2beNICE/h2020-sfs-2016-2, ref.728018; PRIME/h2020-SC1-BHC-2018-2020, ref: 847879).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Dairy product consumption and changes in cognitive performance: two-year analysis of the PREDIMED-Plus Cohort

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Gómez-Gracia, Enrique
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Lluis
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín-Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Barabash Bustelo, Ana
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Coltell, Oscar
  • Gómez-Martínez, Carlos
  • Zomeño, María Dolores
  • Donat Vargas, Carolina
  • Goicolea-Güemez, Leire
  • Bouzas, Cristina
  • García de la Hera, Manuela
  • Chaplin, Alice
  • García-Ríos, Antonio
  • Casas, Rosa
  • Cornejo-Pareja, Isabel
  • Santos Lozano, José Manuel
  • Rognoni, Teresa
  • Saiz, Carmen
  • Paz-Graniel, Indira
  • Malcampo, Mireia
  • Sánchez Villegas, María Almudena
  • Salaverria-Lete, Itziar
  • García-Arellano, Ana
  • Schröder, Helmut
  • Salas-Salvadó, Jordi
Scope: Dairy consumption has been suggested to impact cognition; however, evidence is limited and inconsistent. This study aims to longitudinally assess the association between dairy consumption with cognitive changes in an older Spanish population at high cardiovascular disease risk. Methods and results: Four thousand six hundred sixty eight participants aged 55–75 years, completed a validated food frequency questionnaire at baseline and a neuropsychological battery of tests at baseline and 2-year follow-up. Multivariable linear regression models are used, scaled by 100 (i.e., the units of β correspond to 1 SD/100), to assess associations between baseline tertile daily consumption and 2-year changes in cognitive performance. Participants in the highest tertile of total milk and whole-fat milk consumption have a greater decline in global cognitive function (β: –4.71, 95% CI: –8.74 to –0.69, p-trend = 0.020 and β: –6.64, 95% CI: –10.81 to –2.47, p-trend = 0.002, respectively) compared to those in the lowest tertile. No associations are observed between low fat milk, yogurt, cheese or fermented dairy consumption, and changes in cognitive performance. Conclusion:Results suggest there are no clear prospective associations between consumption of most commonly consumed dairy products and cognition, although there may be an association with a greater rate of cognitive decline over a 2-year period in older adults at high cardiovascular disease risk for whole-fat milk., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six coordinated FIS projects leaded by J.S.-S. and J.Vi., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/ 02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/ 01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/ 00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/ 01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/ 00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S.; the European Research Council (Advanced Research Grant 2014– 2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO/2021/021 grants from the Generalitat Valenciana; the SEMERGEN grant; Juan de la Cierva–Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds to JK. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). J.N. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). C.G.-M. is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). I.P.-G. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). J.S.-S., senior author of this paper, was partially supported by ICREA under the ICREA Academia program.